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ABSTRACT
PHOTOBIOMODULATION IN INHERITED RETINAL DEGENERATION
by
Sandeep Gopalakrishnan
The University of Wisconsin-Milwaukee, 2012
Under the Supervision of Professor Janis T. Eells
The retinal degenerative disease, retinitis pigmentosa (RP), is the most common cause of
inherited blindness in the developed world and is caused by the progressive degeneration
of rod photoreceptor cells preceding cone degeneration. Mitochondrial dysfunction and
oxidative stress have been shown to play a significant role in the pathogenesis of RP and
other retinal degenerative diseases. A growing body of evidence indicates that exposure
of tissue to low energy photon irradiation in the far-red to near-infrared (NIR) range of
the spectrum, (photobiomodulation or PBM) acts on mitochondria-mediated signaling
pathways to attenuate oxidative stress and prevent cell death. These studies tested the
hypothesis that PBM acts in the retina to promote mitochondrial integrity and function,
prevent photoreceptor cell death and preserve retinal function in an established rodent
model of retinitis pigmentosa, the P23H rhodopsin transgenic rat. Retinal function,
structural integrity, surviving photoreceptors and the mitochondrial redox state were
assessed using electroretinography, spectral domain optical coherence tomography,
histomorphometry and cryofluorescence redox imaging. PBM did not alter the structural
and functional characteristics of retina in a non-dystrophic animal strongly supporting the
safety of PBM. Establishing the safety of PBM is essential to advance the therapy to
clinical use. 830 nm PBM exerted a robust retinoprotective effect compared to 670 nm
ii

PBM in the P23H transgenic rat model. 830 nm PBM during the critical period of
photoreceptor degeneration in P23H transgenic rat profoundly attenuated retinal
degeneration resulting in the preservation of retinal function; retinal morphology and
retinal metabolic state in comparison to the sham-treated group. An in vivo longitudinal
study corroborated the structural preservation observed in the cross-sectional study.
These findings provide evidence supporting the therapeutic utility of PBM in the
treatment of retinal degenerative disease. They also further our understanding of the
mechanism of action of PBM by showing that it improves mitochondrial function in the
retinae of RP animals. By exploiting, the cells own mechanism of self-repair, PBM has
the potential for translating into clinical practice as an innovative, non-invasive standalone or adjunct therapy for the prevention and treatment of retinal diseases.
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CHAPTER 1
LITERATURE REVIEW
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The vertebrate retina, is involved in generating visual perception in the visible range of
the electromagnetic spectrum (400-760nm). Photoreceptors are key elements of the outer
sensory retina that are activated by light. The first neuroanatomical studies revealing the
complexity of the retinal structure were described in avian retinae by Santiago Ramon
Cajal in 1888 (Piccolino, Strettoi et al. 1989). Light enters the vertebrate eye by the
refraction at the corneal air interface. The lens focuses the light rays into the thin neural
tissue-retina, which processes and extracts information from the inverted image. The
vertebrate retina has a layered structure. The outermost layer contains the photoreceptors.
There are two distinct types of photoreceptors, rods and cones, which can be
differentiated morphologically (Figure 1). Cones (~5% of total photoreceptors) are small
cone-shaped cells whereas rods (~95% of the total photoreceptors) are larger rod-shaped
cells. Rod cells, containing rhodopsin pigment, are highly sensitive to low light intensity
and have a low photon saturation threshold which enables night vision, whereas cone
cells are for high resolution and color vision. Photoreceptors have specialized structures
called outer segments that are considered to be modified cilia and contain the enzymes
and the proteins responsible for phototransduction. The outer segments discs are
continuously replenished by the phagocytic function of retinal pigment epithelium (RPE).
The RPE also reduces the backscattering of light that enters the eye. The photoreceptors
have a distinct distribution in the retina. In the peripheral retina the rod photoreceptors
are abundant. In the central retina-fovea, the cone density is at a maximum. The second
layer of the retina has intervening neurons including bipolar cells, horizontal cells and
amacrine cells and the third layer, the ganglion cell layer, is the final output layer to the
visual cortex.
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Figure 1 Both rod (A) and cone (B) photoreceptor consist of four distinct regions:
an outer segment (OS) which contains stacks of bilipid membranous discs
embedded with photopigments which are responsible for photoabsorption and
initiation of phototransduction cascade, an inner segment that contains
biosynthetic and metabolic functions as well as optical functions which by the
phenomenon of total internal reflection confines the photons within the receptor
(Hoang, Linsenmeier et al. 2002), a cilium connecting both the inner and the outer
segments, and a synaptic terminal which signals to the inner retina by
neurotransmitters. (Reproduced from Neuroscience. 2nd edition. Purves D,
Augustine GJ, Fitzpatrick D, et al., editors. Sunderland (MA): Sinauer Associates;
2001).
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EVOLUTION OF PHOTORECEPTORS
Historically it has been shown that the vertebrate retina evolved as two independent
systems based on the nature and function of photoreceptors which enabled vision for both
nocturnal and diurnal animals in the ancient visual landscape (Collin, Davies et al. 2009).
The photoreceptor cell and the associated pigment cells enabled primitive life forms to
move in the direction of light for phototaxis (Arendt 2003). Additional cell types including
lens cells, various supporting cells and muscle cells were added as the eye evolved and cell
diversity is at a maximum in the vertebrate eye. Retinal tissue in vertebrates evolved
during the development from the embryonic forebrain as an out-pocketing of the
diencephalon, referred as the optic vesicle which further undergoes invagination to form
the optic cup (Figure 2). The inner wall of the optic cup develops into retina and the outer
wall develops into RPE.
.

Figure 2 Development of anatomical structures of eye from the optic vesicle.
(Reproduced from Neuroscience. 2nd edition. Purves D, Augustine GJ,
Fitzpatrick D, et al., editors. Sunderland (MA): Sinauer Associates; 2001).
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ROD OUTER SEGMENT AND RHODOPSIN
The shape of the outer segment of photoreceptors has been used to characterize its
morphology and function. The photoreceptor has evolved unique structural, functional and
biochemical specializations that enable the process of photoabsorption. The photoreceptor
outer segment is a modified cilium that connects to the inner segment via a connecting
cilium (Figure 1) which maintains the cytoplasmic connectivity. The outer segment has
hundreds of stacked membranous disks surrounded by plasma membrane (Figure 3). The
evagination and invagination of membranes form the base of the cilium results in the
generation of outer segment. In rods the expanding membranes get detached and remain as
free floating discs whereas in cones they remain attached to the outer segment membrane
(Steinberg, Fisher et al. 1980).
The outer segment of the photoreceptor is a dynamic structure and the length is maintained
constant by shedding the distal end followed by its phagocytosis by the retinal pigment
epithelium, while nascent membrane biogenesis occurs at the base of the outer segment
(Young and Bok 1969). The process of rod outer segment shedding and renewal is better
understood than the cones and it follows a circadian pattern; there is increased shedding in
presence of light and decreased shedding in dark (Goldman, Teirstein et al. 1980).
Complete outer segment turnover period is approximately 10 days in normal SpragueDawley rats but it alters when an animal is moved to a new intensity of light. The rod outer
segment shortens during the first three days in a new intensity and later it lengthens, after
which the outer segment length, as well as the rhodopsin content, is inversely related to the
light intensity in the environment. This phenomenon is described as photostasis and it is
believed to have evolved to adapt to variations in day-light intensity and duration
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(Schremser and Williams 1995). The exact reason for outer segment renewal is unclear,
but studies suggest that it confers plasticity to the rod photoreceptor and protects against
damaging effects of constant light exposure (Penn, Tolman et al. 1992).

Figure 3 The outer segment of the photoreceptor is a modified cilium containing
numerous discs which has embedded light sensitive visual pigments. (Reproduced
from Steinberg, Fisher et al. 1980)

Rod photoreceptors are highly specialized neurons that have low spatial resolution, but
high sensitivity and can detect a single photon. Conversely, cone photoreceptors are
relatively insensitive to light with high spatial resolution and are therefore, responsible for
visual acuity (Lamb, Baylor et al. 1979). The visual pigment Rhodopsin (Rho) is the
predominant integral membrane protein (~ 50% of the disc surface area) in rods which
occupies the membranes of the outer segment (Ridge and Palczewski 2007). Vertebral
rhodopsin is a highly specialized G protein-coupled receptor (GPCR) which has seven
transmembrane domains (H1 to H7) (Figure 4). Rho belongs to the class of A GPCRs
within the superfamily and is made up of opsin apoprotein and a chromophore. The opsin
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molecule is synthesized in the inner segment by the Golgi apparatus and is transported to
the outer segment at the area of cilium by fusion using G proteins (Papermaster, Schneider
et al. 1985). The chromophore 11-cis-retinal is a vitamin A derivative (aldehyde of vitamin
A1) which is bound covalently to the terminal amino group of L-lysine residue embedded
in the membrane (Figure 5).

Figure 4 Secondary structure of bovine Rho. The NH2-terminal tail and
extracellular domain point toward the top and the COOH-terminal tail and
cytoplasmic domain is toward the bottom. Letter codes indicate amino acid
residues. The structure has 7 transmembrane α-helical segments (H1 to H7). Inset:
structure of the chromophore -11-cis- retinal. (Reproduced from Menon, Han et
al. 2001).
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Figure 5 A molecular ribbon diagram of inactive and active views of Rho from the
43 Å crystal structure coordinate. Unlike other GPCRs Rho binds to 11-cis retinal
(ligand) covalently both in inactive as well as photo activated state-11-cis dark form
(yellow) to all-trans light (magenta). (Reproduced from Bourne and Meng 2000)

PHOTOTRANSDUCTION
The sequence of events triggered within photoreceptor cells when a single photon is
absorbed is referred as phototransduction and involves the following steps: activation of
Rho, activation of G-protein, activation of effector phosphodiesterase (PDE), hydrolysis of
cyclic guanosine monophosphate (cGMP) and closure of ion channels. Classic studies by
Wald et.al. (1950), first showed that the primary interaction of light with the bound retinal
chromophore is to drive the conversion of 11-cis-to-trans isomerization at the reaction
speed of 10-12 sec (Wald, Durell et al. 1950). The absorption of photons in the visible range
(absorption maximum, λmax~500nm) by 11-cis-retinal is due to the extended polyene
structure of the Rho molecule (Rando 1996). Photoisomerisation makes the Rho molecule
active (R*) which generates spectrally distinct intermediates of Rho (bathorhodopsin,
lumirhodopsin, metarhodopsin I, and metarhodopsin II) that trigger an amplifying cascade
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of biochemical events in the outer segment (Okada and Palczewski 2001). R* stimulates
the G-protein transducin to its activated state (G*), which in turn activates the effector
PDE to PDE*. Activated PDE* causes the hydrolysis of cyclic guanosine monophosphate
(cGMP) to 5’-GMP. The decrease in intracellular cGMP leads to the closure of cGMPgated channels on the plasma membrane of the photoreceptor outer segment, thereby
reducing the influx of sodium ions (Na+) through these channels, which results in
membrane hyperpolarization. Hyperpolarization inhibits or decreases the release of
glutamate at the synapse which is further relayed and processed as a neurochemical event
by the second order retinal neurons and eventually to higher centers in brain. Following
excitation by a photon of light, the photoreceptor returns to its dark state by decay of R*.
The protein arrestin blocks the ability of R* to convert transducin to G* which accelerates
the decay of R* (Figure 6). The all-trans chromophore dissociates from opsin and is
converted back to 11-cis-retinal and is transported out of the outer segment into the RPE
where 11-cis-retinal combines with opsin to regenerate new Rho (McBee, Palczewski et al.
2001).
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Figure 6 Schematic representation of phototransduction cascade in rod
photoreceptors. (Reproduced from Burns and Arshavsky 2005)

In the dark, the photoreceptor is in a depolarized state (~ -40 mV) and a steady current
known as dark current flows through the photoreceptor cell. Recovery in dark is achieved
by the reopening of the cGMP-gated channel by the binding of cGMP on the cytoplasmic
side of the channel. Although Ca2+ and Mg2+ ions are involved, the inward current is
mediated by Na+ influx and the outward current is carried largely by potassium ions (K+)
flowing in the photoreceptor inner segment through K+ sensitive non-gated channels (Yau
and Nakatani 1984). The photoreceptor is in a depolarized state at this stage and there is
constant release of glutamate from the synaptic terminal.
The direct pathway for visual signal processing is the vertical transduction pathway which
transfers neurochemical signals from photoreceptor cells, to bipolar cells, to ganglion cells,
to the optic nerve by synaptic connections. Lateral inputs from horizontal cells
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(photoreceptor-bipolar synapse) and amacrine cells (bipolar-ganglion cell synapse)
modulate this pathway in the retina and provide feedback connections (Figure 7).
Glutamate is the major excitatory neurotransmitter released in the synapses. Once released
from the presynaptic terminal of the photoreceptors, glutamate diffuses across the synaptic
cleft and binds to the receptors (ionotropic and metabotropic glutamate receptors) located
on the dendrites of the postsynaptic neurons (ON-center and OFF-center bipolar cells).

Figure 7 Schematic representation of information flow in the retina. Signals can
pass both vertically and laterally. (Reproduced from Lagnado 2000)

Neurons within the OFF-pathway (horizontal cells, OFF-bipolar cells, amacrine cells, and
ganglion cells) express functional ionotropic glutamate receptors and glutamate binding
onto these receptors opens cation channels, depolarizing the postsynaptic cell membrane.
Glutamate binding onto metabotropic glutamate receptors (APB receptor, present in ON-
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bipolar cells) can have a variety of effects depending on the second messenger cascade to
which the receptor is linked. Thus, postsynaptic responses to glutamate are determined by
the distribution of receptors and transporters (to prevent glutamate induced toxicity) which
in turn determine the signal conductance mechanisms underlying visual information
processing within the ON and OFF-pathways.
High metabolic demand of photoreceptors
Phototransduction is a highly energy demanding process and the energy metabolism is a
critical function that determines photoreceptor function and survival. Like other neurons
of the central nervous system, photoreceptors use ATP generated from glucose as their
energy source and a decrease in the availability of glucose has been shown to accelerate
photoreceptor death and subsequent loss of vision (Umino, Everhart et al. 2006). Vision is
lost when blood supply to the eye is blocked for only 10 seconds (Linsenmeier 1990).
Energy demand of photoreceptors resembles that of rapidly dividing cancer cells (Vander
Heiden, Cantley et al. 2009). Oxygen microelectrode studies have shown that
photoreceptors consume approximately three to four times more oxygen than any other cell
in the central nervous system (Braun, Linsenmeier et al. 1995). Photoreceptors metabolize
glucose either anaerobically by glycolysis or aerobically by oxidative phosphorylation.
Both rod dominated and cone dominated retinae use >80% of glucose for anaerobic
glycolysis even in the presence of oxygen (Chertov, Holzhausen et al. 2011). Glucose
enters the photoreceptors through the Glut-1 transporters present in the inner segment
which is the site for high oxidative activity (Figure 8). Glucose is then phosphorylated by
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hexokinase 2 and transported to the other parts of the photoreceptor cell (Gospe, Baker et
al. 2010).
Dense aggregates of mitochondria fill the apical region of photoreceptor inner segments
and intraretinal oxygen profiles show a deep trough in the oxygen partial pressure at this
site. A high concentration of oxidative enzymes indicates the unusually large amount of
oxidative energy generated (Yu, Cringle et al. 2004) (Lowry, Roberts et al. 1956). Na+/K+
ATPase activity, which is essential for the Na+ transport and the maintenance of the
photoreceptor dark current is by far the most energy demanding process in
phototransduction (Winkler 1981). Synthesis of high energy phosphate bonds for the rapid
turnover of photoreceptor cGMP also requires an appreciable amount of energy (Ames, Li
et al. 1992).
Winkler investigated the ability of superfused rat retina to utilize substrates other than
glucose for generating ATP and showed that pyruvate maintained the amplitude of Fast
PIII (Intra retinal photoreceptor potential) and maintained the concentration of ATP in the
absence of glucose (Winkler 1981). These results demonstrate that ATP generated by
photoreceptor mitochondrial activity is capable of supporting cellular electrical activity
when glycolytic production of ATP is blocked. Interestingly, when pyruvate was
superfused at higher concentrations (20 mM) it did not completely substitute for glucose as
a substrate in generating functional electrical responsiveness thus providing evidence that
either glycolysis alone or Krebs cycle activity alone can maintain retinae at an optimal
functioning level (Winkler 1981).
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Figure 8 Metabolism in photoreceptors. The high metabolic demand in
photoreceptors is met by adequate supply of glucose and oxygen by the choroidal
vessels through the RPE cells. Oxidative phosphorylation in the mitochondria
provides photoreceptors with adequate amounts of ATP for the high energy
demanding phototransduction process. Increased ROS generated as a result of
mitochondrial phosphorylation is removed by the antioxidant defense mechanisms
involving enzymatic (superoxide dismutase, glutathione peroxidase, and catalase)
and non-enzymatic (natural antioxidant glutathione) endogenous systems. The
constant recycling of the photoreceptor OS and recycling of 11-trans-retinal in the
RPE requires rapid macromolecular synthesis and active transport mechanism.
Studies have shown that activated insulin receptors can up regulate the growth
factor signaling that ends up regulating glycolysis through stimulation of mTOR
phosphorylation. (Reproduced from Punzo, Xiong et al. 2012).
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INHERITED RETINAL DEGENERATIONS
Retinal degeneration is described as a class of human eye diseases characterized by the
loss of photoreceptors leading to severe visual impairment and blindness. Inherited retinal
degenerations (IRDs) are a genotypically and phenotypically diverse category of
inherited diseases characterized by the loss or premature death of rod and cone
photoreceptor cells leading to severe visual impairment and blindness in all ages and
racial backgrounds. In most inherited retinal degenerations both the rod and cone
photoreceptors die, but the degree to which the two cell types are affected differs with
different disorders. Over the years, knowledge of gene mutations associated with IRDs
has quickly grown and many disease related gene abnormalities have been mapped and
identified. 148 genes and 186 loci have been identified with various IRDs
(www.sph.uth.tmc.edu/RetNet/disease.htm;www.retina-international.com). Due to the
heterogeneous nature of retinal degenerations many associated mutations have yet to be
identified, emphasizing the need for additional research and the development of
additional animal models.
Retinitis Pigmentosa (RP)
Retinitis Pigmentosa (RP) is a large genetically heterogeneous group of IRD and the most
common cause of inherited blindness in the developed world. RP affects about one in 5000
individuals worldwide (Hartong, Berson et al. 2006). The age at which the individuals
show symptoms ranges from 30 to 60 years of age and even varies significantly between
individuals in the same family. Molecular genetic techniques have revealed that 30-40% of
RP cases are autosomal-dominant, 50-60% are autosomal-recessive and 5-15% are an X-
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linked trait. Individuals with an autosomal dominant trait generally retain vision longer
than those with autosomal recessive or X-linked traits (Dryja, McGee et al. 1990) (Berger,
Kloeckener-Gruissem et al. 2010). Non Mendelian inheritance patterns such as
mitochondrial inheritance (maternal) are reported in a small proportion of cases (Kajiwara,
Berson et al. 1994). The symptoms of RP are well characterized and affected individuals
report impaired dark adaptation, night blindness and loss of peripheral vision.
Characteristic clinical features in RP include thinning of pigment epithelium and retinal
vasculature, optic disc pallor and classic pigmentary deposits referred as 'bone spicule'
(Figure 9). There is an exponential loss of visual field area (2.6–13.5% loss annually) and
electroretinogram amplitude (8.7–18.5%) in affected individuals. In 20-30% of the
individuals affected by RP, the disease is associated with non-ocular diseases including
Usher’s syndrome (type I and II), Bardet-Biedl syndrome and Refum’s disease (Hartong,
Berson et al. 2006). Mutations in many rod photoreceptor specific genes including
rhodopsin, arrestin and rod outer segment membrane proteins result in photoreceptor
degeneration (Phelan and Bok 2000). In addition mutations within the RPE - CRALBP
mutations and RDH5 mutations result in photoreceptor degeneration.

Figure 9 Fundus image of a normal (left) vs. RP eye (right). (Reproduced from
Farrar, Kenna et al. 2002)
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Causal genes of Retinitis Pigmentosa
Although the majority of RP cases are monogenic, the disease is characterized by its
genetic heterogeneity. Researchers have identified mutations in 45 gene loci which cause
RP (Berger, Kloeckener-Gruissem et al. 2010). The first gene abnormality in RP was
reported in 1984 and was associated with gene for X-linked RP (Bhattacharya, Wright et
al. 1984). In 1989, first autosomal RP (adRP) gene was localized to 3q. This mutation was
a single-base substitution in codon 23 of rhodopsin gene (RHO) and it accounts for 12% of
autosomal dominant RP in US (Dryja, McGee et al. 1990). This mutation within the
rhodopsin gene at codon 23 in one allele causes a change from proline to histidine in the
23rd amino acid (P23H) of the rhodopsin molecule, which results in misfolding and
mislocalization of the protein. This mutation results in an

autosomal dominant RP

phenotype characterized by night blindness (nyctalopia) during adolescence resulting
from

the initial loss of rod photoreceptors that carries the mutation followed by

progressive loss of vision in adulthood resulting from the secondary degeneration of
cones, loss of retinal vasculature and optic disc pallor (Berson, Rosner et al. 1991). The
second most observed adRP locus was on 6p and coded for mutations in retinal
degeneration slow (RDS) gene encoding a vital component of OS disc membrane
glycoprotein- Peripherin. Mutations in the peripherin/RDS gene are often associated with
less progressive disorders and sometimes with atypical findings, including early macular
involvement.
The other common gene mutations seen in rod dominated retinal and vitreoretinal diseases
including RP are classified in Figure 10. This includes ABCA4, USH2A, arrestin, MERTK,
PRKCG, ROM-1, RPE 65, PDE6A etc., highlights functional diversity and investigators
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still believe that about 40% of RP cases are due to genes that are yet undiscovered. In
summary, the linkage studies done in early 1990s investigating mutations revealed the
genetic complexity and heterogeneity associated with retinal degeneration.

Figure 10 Classification of rod dominated retinal and vitreoretinal diseases
including RP and casual genes. (Reproduced from Berger, Kloeckener-Gruissem
et al. 2010).
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Identified genes in RP normally encode for proteins that are essential for phototransduction
cascade (RHO, PDE6A), vitamin A metabolism (ABCA4, PRE65), rod outer segment
protein (ROM1), cell signaling (SEMA4A), cell-cell interaction (CDH23), RNA intronsplicing factors (PRPF31), intracellular trafficking proteins (MYO7A), phagocytosis
(MERTK) and proteins for pH regulation (CA4) (Hartong, Berson et al. 2006). Loss of
rod photoreceptors leading to altered retinal architecture (Figure 11 and Figure 12) is the
outcome of abnormal physiology associated with mutated or absent gene products.
Biochemical interaction between rods and cones and the mechanisms of secondary death of
cones following rod mutations and the role of rod derived cone viability factors (RdCVF)
in the degeneration process are still not clearly understood.

Figure 11 Loss of retinal architecture in RP demonstrated by high resolution
microscopy.(Reproduced from http://www.nei.nih.gov/eyeonnei/snapshot/archive/
0909.asp)
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Figure 12 Schematic representation of photoreceptor loss in Retinitis Pigmentosa.
Normal Retina (A), when rods start to die (B), extensive loss of rod photoreceptor
as the disease progresses (C) and eventually retina will lose all the rod
photoreceptors which results in reduced nutrient flow, which leads to the death of
remaining photoreceptors and the loss of retinal architecture. (Reproduced from
Punzo, Xiong et al. 2012).

Therapeutic Approaches for the Treatment of RP
There is presently no effective treatment for RP. A three year follow-up study on the
natural course of RP has shown that patients with dominant, recessive, and X-linked RP
taking vitamin A, Vitamin E or both

showed slower decline in electroretinography

amplitudes compared to those not taking any supplements but the visual-field area and
visual acuity was not significantly different between groups (Berson, Sandberg et al.
1985). A study investigating the role of docosahexaenoic acid (DHA), an omega-3 fatty
acid, did not show a clear benefit (Hoffman, Locke et al. 2004). Based on the findings in
two animal models of RP it is postulated that reduction in the exposure to light can slow
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down the rate of degeneration (Naash, Peachey et al. 1996). Use of pharmacological
agents including carbonic anhydrase inhibitors has been shown to decrease the secondary
pathology associated with RP including edema of the macula (Fishman, Gilbert et al.
1989). Valproic acid is an inhibitor of histone deacetylase and

is identified as a

pharmacologic chaperone for treating RP and an active clinical trial is currently going on
(Clemson, Tzekov et al. 2011).
The recent advances in finding a cure for RP are based on gene specific therapies,
transplantation of lost retinal tissue by tissue engineered grafts/encapsulated cell
technologies, regeneration by pluripotent stem cells and the use of retinal prosthetic
devices. Gene specific therapies are based on the type of mutation and substantial
improvement towards clinical trials is made on experiments in animal model targeting
RPE65 gene (Bennett, Tanabe et al. 1996). Gene silencing and interference RNA(RNAi)based gene therapy is being developed for dominantly inherited mutations (Cashman,
Binkley et al. 2005). The potential use of transplanting RPE, photoreceptors or pluripotent
stem cells is being widely investigated and studies have shown beneficial effects
(Whiteley, Litchfield et al. 1996). Prosthetic devices that can electrically stimulate the
optic nerve, optic nerve head and the visual cortex and being tested in patients (Rizzo,
Wyatt et al. 2003; Roessler, Laube et al. 2009). A clinical trial with second-generation
electronic retinal implant-Argus II Retinal Stimulation System is ongoing and the implant
is designed to take the place of degenerated photoreceptors in RP (www.clinicaltrials.gov).
One difficulty in the treatment of RP is that many patients have already lost all or nearly all
rod photoreceptors when they complain about compromised vision thus strategies should
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be developed that can rescue the few remaining cone photoreceptors. Despite the advances
mentioned above there is a clear need for a neuroprotective therapy that has the potential to
attenuate photoreceptor cell loss during the course of the disease. Photobiomodulation
holds the promise to be a retinoprotective non-invasive therapy for the prevention and
treatment of retinal diseases.
Animal Models of Retinitis Pigmentosa
In most inherited retinal degenerations both the rod and cone photoreceptors die, but the
degree to which the cell types are affected differs with different disorders and this
heterogeneity is the biggest barrier and challenge in designing and developing
therapeutics. Due to the heterogeneous nature of RP many associated mutations have yet
to be identified which calls for additional research and better animal models. Both
transgenic mice (Pde6brd10, rd11, Crb1rd8, nr, Tubtub, Rpe65rd12) and rat (P23H, S334ter)
have been extensively used to understand the molecular mechanisms involved in
inherited retinal degeneration.
The first retinal degeneration animal model was the Pde6brd1 mouse model discovered by
Keeler in 1924, which demonstrated early-onset severe degeneration due to the lack of
PDE 6 activity in the rod photoreceptors. This same phenotypic resemblance is found in
patients suffering from adRP (Keeler 1924). The Pde6brd1 mouse model

was

successfully used in developing novel therapeutic strategies to rescue rod degeneration
by gene therapy. Cone degeneration has been prevented by introducing autologous bone
marrow derived hematopoietic stem cells into the degenerating retinal vasculature
(Takahashi, Miyoshi et al. 1999) (Otani, Dorrell et al. 2004). The Pde6brd10 (rd 10) mouse
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model displays retinal degeneration with sclerotic retinal vessels by p28 and resembles a
model of autosomal recessive mutation that maps to the chromosome 5. Pde6brd10 is
considered to be a better model than Pde6brd1 for developing pharmaceutical therapies
and testing neuroprotective approaches for RP because of its later onset and mild
degeneration phenotype. The shape and size of mouse eyes are challenging for surgical
procedures and this led to the development of rhodopsin transgenic rat models which
have larger eyes.
The P23H transgenic rat is a model of autosomal dominant RP in which the rhodopsin
transgene mimics a human form of RP common in North America (Dryja, McGee et al.
1990). The transgene induces an autosomal dominant photoreceptor degeneration
phenotype that renders the outer retina hyperoxic from early postnatal life (Wellard, Lee
et al. 2005). As photoreceptors degenerate in P23H model, oxygen consumption
decreases and oxygen tension increases in the outer retina. Choroid capillaries have been
shown to auto regulate poorly to the changing hyperoxic environment and this is known
to cause constriction of retinal vessels in P23H transgenic rats, the RCS rat model and in
the Abyssinian cat model of retinal degeneration (Yu, Cringle et al. 2004). Hyperoxia
induced oxidative stress and reduced levels of antioxidant systems includin catalase
render the retina particularly vulnerable to progressive degenerative processes. Increased
oxidative stress activates fibroblast growth factor (FGF) and ciliary neurotrophic factor
(CNTF) which results in a slower degeneration process that continues throughout life
(Machida, Kondo et al. 2000).
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Mechanisms of retinal degeneration have also been studied using induced degeneration
models. In induced models physical (e.g., light) or chemical (e.g. nitrosourea) exposure to
wild type or genetically engineered animals results in the induction of photoreceptor
degeneration leading to different phenotypes of retinal degeneration from mild to severe.
Induced models have the advantage of control over disease severity and onset. Many toxic
agents (alkylating agent; N-Nitroso-N-methylurea) and strategies including iron overload
and autoantibody treatments have been reported in the literature to induce the
photoreceptor degeneration process in rodents (Yuge, Nambu et al. 1996), (Nambu, Yuge
et al. 1997), (He, Poblenz et al. 2000). The most widely accepted induced rodent model is
the light induced retinal degeneration model (LIRD) (Noell, Walker et al. 1966). The
advantage of the induced model is that the severity of retinal damage can be adjusted
according to the experimental needs.
Mitochondrial dysfunction, oxidative stress and apoptosis in retinal degenerations
Photoreceptors are the most metabolically active cells in the body. They have a dense
concentration of mitochondria in their inner segments to provide ATP for the energyintensive processes of outer segment renewal and maintenance of the dark current
(Bramall, Wright et al. 2010). Considerable evidence supports a key role for
mitochondrial dysfunction and oxidative damage in the pathogenesis of photoreceptor
cell death in RP and other retinal degenerative disorders (Campian, Qian et al. 2004).
Human retinal dystrophies and degenerations and light-induced retinal degeneration have
been associated with profound loss of retinal antioxidant systems and cytoprotective
factors thus compromising the ability of retinal neurons and glia to protect against
oxidative damage leading to apoptotic cell death (Carmody and Cotter 2000).
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Mitochondrial dysfunction is also reported in a broad spectrum of pathologies including
Parkinson’s disease, Alzheimer’s disease, Huntington’s disease, amyotrophic lateral
sclerosis and many other neurodegenerative diseases
Reactive oxygen species (ROS) are formed as the by-product of oxidative
phosphorylation in the electron transport chain (ETC) of the mitochondria. There are
important antioxidant systems including mitochondrial superoxide dismutase (MnSOD),
glutathione (GSH) and thioredoxin to keep the concentrations of free radicals at a
minimum and to prevent conversion to stronger oxidants. The inability of the antioxidant
systems in the cell to quench the increased production of free radicals creates a
biochemical imbalance referred as oxidative stress (Ceriello and Motz 2004). The
production of reactive oxygen species and oxidative damage is increased under
conditions of mitochondrial dysfunction (Shen, Yang et al. 2005). The ROS generated
attack lipids, proteins and nucleic acids and disrupt their functions. The metabolic
products generated by ROS interactions with these cellular components also disrupt
major functions including energy metabolism, signal transduction, intracellular transport
and various other functions. A key ROS molecule, superoxide (O2–. ), becomes highly
reactive when combined with NO to form peroxynitrite (ONOO-) and these potent
oxidant molecules can oxidize chemical moieties including lipids, proteins and DNA and
causing irreversible damage to them. These toxic reactions often result in cell death by
apoptosis or necrosis (Butterfield, Reed et al. 2007). There is strong evidence regarding
the link between oxidative stress and photoreceptor damage in various in vivo and in vitro
experimental models (Vlachantoni, Bramall et al. 2011).
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In many IRDs the defective gene is present in the rod photoreceptor, rod cell death
precedes the cone cell death, and the mechanisms by which cone cells undergo apoptosis
are still not clear. IRDs characterized by common rhodopsin mutations cause protein
misfolding and retention in the endoplasmic reticulum (ER) which causes ER stress. ER
stress activates sensor proteins that results in unfolded protein response (UPR) and
activation of signaling pathways including ATF6 and PERK. These pathways reduce the
translation and accelerate misfolding of protein. These abnormal proteins accumulate in
the rods as opsin aggresomes. Similar proteinacious inclusions are reported in many
forms of neurodegeneration, including amyotrophic lateral sclerosis, Alzheimer's disease
and Parkinson’s disease (Saliba, Munro et al. 2002). Oxidative stress is also generated in
IRDs due to reduced oxygen utilization by inactive mutant rod photoreceptors resulting
in outer retinal hyperoxia which generates ROS and this is confirmed in MertkRCS/RCS rats,
Tg. RhoPro23His (P23H) rats, and CEP290 mutant cats (Yu, Cringle et al. 2004) (PadnickSilver, Kang Derwent et al. 2006). ROS thus generated can cause post translational
modification of thiol groups of enzymes and transcription factors leading to the activation
of proapoptotic pathways thus decreasing photoreceptor survival (Janssen-Heininger,
Mossman et al. 2008).
Accumulation of mitochondrial ROS influences both retrograde (mitochondria to
nucleus) and anterograde (nucleus to mitochondria) redox sensitive signaling pathways
which are capable of initiating the process of apoptosis. Potential redox sensitive
signaling components that cause photoreceptor cell death in IRDs are p53 (Ali, Reichel et
al. 1998) and HDAC4 (Chen and Cepko 2009), but based on the nature of the
photoreceptor stress many other pro and antiapoptotic factors are involved. Cell death by
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apoptosis (both caspase dependent and caspase independent) is a unifying feature in
various forms of inherited photoreceptor degenerations (Bramall, Wright et al. 2010). In
several different rodent models of inherited retinal degenerations, aberrant photoreceptor
apoptosis is demonstrated during the critical period of photoreceptor development in the
retina.

NEAR INFRARED (NIR) PHOTOBIOMODULATION
Treatment of tissue with monochromatic photons in the far-red to near-infrared (NIR)
region of the spectrum (λ=630-1000 nm), also known as photobiomodulation (PBM),
improves mitochondrial function and promotes cell survival in cultured cells and animal
models of disease (Liang, Whelan et al. 2006) (Desmet, Paz et al. 2006). PBM has been
used clinically to treat soft-tissue injuries and stimulate wound healing for more than 40
years (Eells, Henry et al. 2003). Photobiomodulation at wavelengths between 630-830
nm at doses ranging from 3-6 J/cm2 has been shown to reverse harmful effects of neuro
and developmental toxins, accelerate wound healing in murine diabetic models of wound
healing, improve recovery from ischemic reperfusion injury in the heart, prevent oral
mucositis in pediatric bone marrow transplant patients and attenuate retinotoxic effects of
methanol-derived formic acid in rodents (Wong-Riley, Liang et al. 2005), (Lim, Sanders
et al. 2010), (Eells, Henry et al. 2003), (de Sousa, Santos et al. 2010).
Recent studies have demonstrated that 670nm NIR photons delivered transcranially to the
injury site in an in vivo model of partial optic nerve transection, a model of traumatic
injury in the central nervous system, resulted in a decrease in secondary oxidative stress
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in astrocytes, an increase in NG-2 immunopositive oligodendrocyte precursor cells
(OPCs) and restored visual function (Fitzgerald, Bartlett et al. 2010). NIR photons have
also been shown to induce neuroprotection and stimulate neural maturation in vitro in a
rat pheochromocytoma cell line 12 (PC12) following oxidative stress and prevent
rotenone-induced decreases in visual function in vivo by increasing cytochrome c oxidase
and superoxide dismutase activity (Giuliani, Lorenzini et al. 2009) (Rojas, Lee et al.
2008).
Studies in rodent models of Parkinson’s disease and multiple sclerosis demonstrated that
treatment with PBM reduced the severity of disease and decreased concentrations of
cytotoxic and pro-apoptotic factors (Liang, Whelan et al. 2006). The prolonged effect of
brief PBM treatment is consistent with the induction of signaling cascades that initiate
gene expression, protein synthesis, and oxidative metabolism in damaged cells (Karu,
Pyatibrat et al. 2004). In a model of toxin induced retinal dysfunction, microarray
analysis showed that gene expression pathways involved in mitochondrial metabolism
and cytoprotection were up regulated whereas pathways involved in cell death were down
regulated. Studies to identify the genes and noncoding RNAs (ncRNAs) involved in the
neuroprotective actions of NIR-PBM in light induced retinal degeneration model
demonstrated 44 known genes and 6 ncRNAs whose expression was significantly
increased in light damage, was reduced below criterion when the retina was conditioned
by PBM (Natoli, Zhu et al. 2010). Thus, existing data demonstrate the efficacy and
therapeutic potential of NIR PBM.
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The mechanism of near-infrared photobiomodulation
Mechanistically, light in the spectrum of 630-1000 nm is hypothesized to interact with
the mitochondrial enzyme cytochrome c oxidase, triggering signaling mechanisms
(Figure 13) that result in improved mitochondrial energy metabolism, antioxidant
production and cell survival (Liang, Whelan et al. 2006) (Desmet, Paz et al. 2006)
(Wong-Riley, Liang et al. 2005). The cytoprotective action spectrum of NIR light
corresponds with the cytochrome c oxidase absorption spectrum (Figure 14).
Comparative spectral analysis for transition metals and their complexes and the
biomolecules associated with cellular metabolism suggests that multinuclear enzyme
containing Cu(II) complexes are involved in the cellular mechanisms of action of NIR
(Karu 1999). Comparing d-d transitions and charge transfer complexes of Cu with the
action spectrum have revealed that the photoacceptor molecule is the terminal enzyme of
the electron transport chain- cytochrome c oxidase. Mixed valence copper components of
cytochrome c oxidase, CuA and CuB are believed to be the photoacceptor center of the
molecule. Cytochrome c oxidase plays a central role in the bioenergetics of the cell and
it can also initiate secondary cell signaling pathways that activate transcription factors,
alter gene transcription and enhance protein synthesis of antioxidants and other proteins
creating a stable microenvironment for cell survival (Figure 13) (Karu 2010), (Desmet,
Paz et al. 2006).
Two pathways are widely accepted as the starting point of cellular signaling inside the
cell following the interaction of NIR photons with the catalytic center of the cytochrome
c oxidase. One of them is the photodissociation of NO from the binding sites on the heme
iron and copper centers of cytochrome oxidase allowing oxygen to rebind to these sites
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and restore normal mitochondrial respiration (Sarti, Giuffre et al. 2003) (Huang, Chen et
al. 2009). Based on the presence or absence of the NO in the catalytic center, Cu A reduced
and CuB oxidized are assumed to be associated with the charge-transfer channels and CuA
oxidized

and CuB reduced of the chromophore are associated with the d-d transition of the

catalytic center which is thought to regulate the downstream signaling effects involved
(Karu 2010). The other pathway associated with the NIR interaction on mitochondria is
the ATP extra synthesis. Excess generation of ATP in the cell is shown to significantly
alter cellular metabolism in tetrodotoxin (TTX) treated primary cultured neurons (WongRiley, Liang et al. 2005) (Figure 14). TTX, a voltage dependant sodium channel blocker,
decreases ATP demand, impedes neuronal impulses and down-regulates cytochrome c
oxidase in primary cultured neurons. ATP thus acts not only as the energy currency of the
cell but also as a critical molecule that can initiate downstream cell signaling. Specific
receptor family that is directly activated by ATP – P2 family and the breakdown product
adenosine-P1 family are identified (Burnstock 2009). These receptors and their subtypes
(P2X, P2Y, P2Y2, P2Y11) are shown to mediate the beneficial effects of NIR PBM and
low level light therapy (Karu 2010). ATP when binds to P2Y receptors initiates a cascade
of molecular evens in the cell, increasing the intracellular Ca2+ ions which can in turn act
as a positive effector molecule for mitochondrial function. The postulated molecular
interaction of NIR photons with cytochrome oxidase initiates a cascade of secondary cell
signaling pathways that activates transcription factors, alters gene transcription and
enhances protein synthesis of antioxidants and other proteins creating a stable
microenvironment for cell survival (Figure 13) (Desmet, Paz et al. 2006) (Whelan,
Buchmann et al. 2003).
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Figure 14 Activity of Neuronal Cytochrome Oxidase and Cellular ATP Correlates
with Cytochrome Oxidase Action Spectrum. Reproduced from (Wong-Riley,
Liang et al. 2005)
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Mitochondrial retrograde signaling in NIR photobiomodulation
The mitochondrion plays a central role in the cell by mediating diverse cellular functions
and integrating signals between the nucleus and the organelle. Mitochondrial retrograde
signaling is defined as the one way communication between mitochondria and the
nucleus that regulates many cellular functions in both normal as well as diseased states
(Butow and Avadhani 2004). The possibility of retrograde mitochondrial signaling was
established with NIR photobiomodulation when studies showed an increase in DNA and
RNA synthesis in cultured cells when irradiated with a range of  from 300 - 860nm,
without a known chromophore in the nucleus that absorbs this range of .
The above possibility was reconfirmed by many investigators using cell proliferation as
the model system because proliferation increases the adhesion of cells to a matrix, as well
as the DNA and RNA synthesis rate (Ryan and Hoogenraad 2007). Current knowledge
about

mitochondrial

retrograde

signaling

in

NIR

photobiomodulation

(Figure 15) demonstrates that it is mediated via mitochondrial membrane potential
(ΔΨm), generation of ROS, altering the [Ca2+] dynamics in the cell, and influencing NO
binding to cytochrome c oxidase (Karu 2008). cDNA microarray study on fibroblasts
irradiated with 628 nm light revealed that 111 genes of 10 functional categories were
upregulated of which seven were directly or indirectly associated with the cell
proliferation. The three other genes upregulated were associated with transcription
factors, inflammation and cytokines (Zhang, Song et al. 2003). Mitochondrial retrograde
signaling in general is considered to be both a stress response and an adaptive response of
the cell. Investigators largely agree that the action associated with near-IR radiation on
mammalian cells and tissues is mostly adaptive in nature. Changes in the dose and
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intensity of irradiation cause cyclic changes in the mitochondrial metabolic activity and
the repose is characterized a bell shaped curve generalized in the Arndt-Schulz law.

Figure 15 Putative mitochondrial retrograde signaling and other associated
cellular events following photoabsorption by cytochrome c oxidase. (Reproduced
from Karu 2008).
Experimental models using isolated mitochondria and whole cells irradiated with
monochromatic radiation in the NIR range has been shown to affect ΔΨm and stimulate
ATP synthesis. Studies using He-Ne laser irradiation of melanoma cells induced a sudden
increase in ΔΨm and ATP concentration which was mediated via increased cytochrome c
oxidase activity which in turn promoted the phosphorylation of Jun N-terminal kinase

34

(JNK) and activator protein-1 (AP-1) expression resulting in an increase in cell
proliferation (Hu, Wang et al. 2007). Superoxide anion (O2•−) generated in mitochondria
as a result of oxidative phosphorylation is the primary ROS molecule that is capable of
altering the retrograde signaling pathway which is established by its relevance in the up
regulation of matrix metalloproteinase-1 (MMP-1) (Schroeder, Pohl et al. 2007). ROS
generation was monitored at the single cell level in real time along with changes in ΔΨm,
intracellular pH and [Ca2+] after irradiation with 647 nm NIR photons (Alexandratou,
Yova et al. 2002). Mitochondria are at the center of the crosstalk between Ca2+, ΔΨm and
ROS which is referred as the love–hate triangle. An increase in intracellular [Ca2+] is
reported following irradiation with light of various wavelengths in mast cells,
hepatocytes, isolated mitochondria and sperm cells (Karu 2008). This increase in
intracellular [Ca2+] is part of mitochondrial retrograde signaling leading to activation of
calcineurin, which in turn leads to the activation of transcription factor NF-κB (Butow
and Avadhani 2004).
Nitric oxide (NO•) is an important intramitochondrial signaling molecule and is generated
in biological systems by nitric oxide synthases. NO directly binds to cytochrome c
oxidase, modulates mitochondrial respiration (Cooper 2002) and is believed to induce
mitochondrial retrograde signaling through altered ΔΨm. By inhibiting cytochrome c
oxidase, NO not only interferes with the oxygen consuming ability of the cell but also
alters the redox status of the respiratory chain and thus generates O2•− (Brookes, Levonen
et al. 2002).
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Coherent light sources like lasers are limited in their ability to deliver far-red to nearinfrared light without producing thermal effects at the tissue interface. Moreover the
narrow beam width makes it difficult to treat large areas using a laser. Non coherent
sources like LED arrays were initially developed by NASA for experimental protocols in
outer space. LED arrays can be tuned to generate light in the far-red to near-infrared
range of the spectrum at optimal wavelengths and energy densities without producing any
thermal effects. Light emitted by LED arrays at optimal wavelengths can penetrate skin
and tissue to a depth of approximately 23 cm (Beauvoit, Kitai et al. 1994). Optimal
wavelengths and energy densities necessary for therapeutic interventions have been
characterized with NIR-LEDs. An energy density of 4 J/cm2 has been shown to be
effective at stimulating biological processes. Further, NIR-LED light therapy has been
deemed a nonsignificant risk by the FDA and has been approved for use in humans
(Desmet, Paz et al. 2006).
Mitochondrial dysfunction and oxidative stress is attributed to the pathogenesis of many
retinal and optic nerve diseases including age-related macular degeneration, diabetic
retinopathy and Leber’s hereditary optic neuropathy (Barron, Johnson et al. 2001).
Oxidative stress plays a central role in laser burn injury, methanol induced retinal toxicity
and many other retinal degenerative diseases (Seme, Summerfelt et al. 1999). Our
understanding of the genetic and molecular mechanisms of retinal degenerations and
retinal injury are incomplete and no efficient therapeutic strategy to prevent or manage
the degenerations does exist. The long term goal should improve mitochondrial function
and attenuate oxidative stress. Although the majority of investigators agree that
cytochrome c oxidase is the major mediator for the beneficial effects of NIR PBM, the
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role played by other cellular photoacceptors including cytochrome b, cytochrome c,
catalase, nitric-oxide synthase and heme-containing proteins including neuroglobin
require additional investigation.
Pilot experiments conducted in collaboration with other investigators have demonstrated
that NIR-PBM administered during the critical period (P10-25) of photoreceptor cell loss
in an established rodent model of retinitis pigmentosa, the P23H-3 rat, increases retinal
mitochondrial cytochrome oxidase activity and protects against apoptotic photoreceptor
cell death. These findings demonstrate the promise of NIR-PBM as a potential noninvasive therapy for the treatment of RP. These preliminary findings also call for a more
thorough understanding of both the efficacy and mechanism of this therapeutic approach
over the disease course. Studies proposed in this dissertation will test the therapeutic
benefit of NIR PBM in the treatment of RP using this established and well-studied animal
model of disease which are essential before NIR PBM can be translated to clinical trials
for the treatment of RP and other retinal dystrophies.

Rationale for the Comparison of 670nm vs. 830 nm light
The optical window for effective tissue penetration of red to near infrared radiation
allows researchers to postulate that possible specific biological effects of irradiation
happens between λ=600 and λ=1000nm. Results from our lab demonstrated that the
irradiation of retinae and optic nerve in vitro at λ=670 nm provided retinoprotection by
increasing the survival and functional recovery of photoreceptors after an acute injury
(Eells, Henry et al. 2003). Following our study many investigators demonstrated similar
retinoprotective and neuroprotective effects with λ=670 nm in both in vivo animal models
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and in vitro culture systems (Wong-Riley, Liang et al. 2005) (Rojas, Lee et al. 2008).
Karu's laboratory, among others, has shown that the mitochondrion is the target organelle
in photobiomodulation and comparative spectral analysis revealed that cytochrome
oxidase acts as a photoacceptor molecule. In many in vitro models studied, two peaks in
the action spectrum of cytochrome oxidase following photon irradiation were observed at
670 nm and at 830 nm which prompted many researchers to focus on these two
wavelengths to identify the cellular mechanisms involved in PBM (Karu 2008).
There is a growing interest in the use and safety of low level light and laser for traumatic
brain injury and neurodegenerative diseases (Zivin, Albers et al. 2009). A non-invasive
transcranial application of 808-nm low level light therapy given 4 h following traumatic
brain injury in a rodent model significantly decreased the lesion volume and preserved
neurobehavioral function (Oron, Oron et al. 2012). Using similar light sources,
investigators have shown an increase in cortical tissue ATP content following embolic
strokes in rabbits (Lapchak and De Taboada 2010). A recently published study compared
the efficacy of both λ=670 nm and λ=810-nm laser treatment in a traumatic brain injury
model and showed that the neurologic severity score decreased by 21% in 670nm and
32% in 810nm treated group when compared to that of the controls (Qiuhe Wu et. al,
Proc. of SPIE Vol. 7552 755206-1).
The above findings led us to conduct a pilot experiment using both 670 nm and 830 nm
in rodent model of inherited retinal degeneration, P23H transgenic rat. The findings from
this experiment demonstrated that 830 PBM treatments using LED monochromatic light
source produced a more robust retinoprotective effect in the P23H rats treated from p10p25 when tested at p30 than the 670 nm treatment for the same intensity. Based on these
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data we propose to examine the retinoprotective efficacy of both 670 nm and 830 nm
LED treatment in P23H transgenic rat.
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CHAPTER 2
PRELIMINARY DATA AND SPECIFIC AIMS
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PRELIMINARY DATA
Mechanistic studies from our lab and other investigators have demonstrated that NIR
photons interact with cytochrome oxidase, in mitochondria, triggering signaling
mechanisms which result in increased efficiency of the electron transport chain (ETC),
improved mitochondrial energy metabolism, up regulation of cytoprotective genes and
improved cell survival in various in vitro and in vivo disease models (Eells, Wong-Riley
et al. 2004).
NIR PBM attenuates the loss of photoreceptors in the P23H rat during the ‘critical
period’ of photoreceptor degeneration.
Photoreceptor death in different P23H strains exhibits a specific pattern. Photoreceptor
death is excessive during the early developmental stages (p10-p25) which is referred as
the ‘critical period’ of photoreceptor degeneration in this dissertation (Figure 16).

Figure 16 Comparison of degeneration rates of ONL in three different lines of
P23H rhodopsin transgenic rat strains with control animal. (Reproduced and
modified from http://www.ucsfeye.net/mlavailRDratmodels.shtml to highlight the
‘critical period’).
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Published work from our lab has shown that NIR PBM is retinoprotective against toxininduced damage, and recent studies have demonstrated that NIR PBM can attenuate
photoreceptor cell death by 70% during the critical period of photoreceptor development
(Figure 17) in the P23H-3 rat indicating that NIR PBM can alter the underlying pathology
during the developmental stages of the retina (Eells, Wong-Riley et al. 2004). Our
hypothesis is that oxidative stress is generated in P23H photoreceptors due to reduced
oxygen utilization by inactive mutant rod photoreceptors resulting in outer retinal
hyperoxia which generates ROS (Stone, Maslim et al. 1999; Yu, Cringle et al. 2004).

Figure 17 Photoreceptor cell death by apoptosis is demonstrated in P23H retina by
TUNEL+ cells and following NIR PBM there is a significant reduction (greater
than 70%) in the number of TUNEL+ cells in the ONL.
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ROS thus generated can cause posttranslational modification of thiol groups of enzymes
and transcription factors, leading to the activation of proapoptotic pathways, thus
affecting the photoreceptor survival particularly during early development. PBM acts to
improve mitochondrial function and to increase antioxidant protection (Geller, Krowka et
al. 2006). PBM-induced improvement of mitochondrial function would increase oxygen
consumption in the P23H retina and reduce oxygen tension and thus reduce oxygen
toxicity (Stone, Maslim et al. 1999). Secondly, it is thought that the PBM-induced
increased production of cytoprotective factors and antioxidants would act in concert to
protect the retina from apoptotic photoreceptor cell death. NIR-PBM administered during
the critical period of photoreceptor development in the P23H-3 rat is neuroprotective.
Photobiomodulation increases cytochrome oxidase concentrations in the P23H
retina.
In vitro studies in our laboratory and by other investigators have shown that NIR PBM
improves photoreceptor oxidative metabolism by increasing mitochondrial cytochrome
oxidase activity and upregulating key antioxidant protective enzymes, cofactors and
neurotrophic factors in the retina, culminating in a significant attenuation of apoptotic
photoreceptor cell death (Karu 1999; Eells, Wong-Riley et al. 2004; Ying, Liang et al.
2008). As shown in Figure 18, NIR PBM significantly increased the concentration of
cytochrome oxidase in the retina of the P23H-3 rat. Density profiling of retinal layers for
specific cytochrome oxidase immunolabeling shows increased labeling density in the
inner segments of the photoreceptor cells, which is consistent with the higher
mitochondrial density in the inner segments of photoreceptors. These findings are
consistent with the in vitro observations and support our hypothesis that upregulation of
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cytochrome oxidase activity is a critical component in the neuroprotective actions of NIR
PBM. Our hypothesis is further supported by studies showing that increased cytochrome
oxidase activity improves respiratory efficiency under conditions of oxidative stress, thus
attenuating the production of reactive oxygen species (Campian, Qian et al. 2004).

Figure 18 A significant up regulation of cytochrome oxidase activity in the inner
segments of photoreceptor cells following NIR PBM is demonstrated by density
profiling (n = 6, p < 0. 001)
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Photobiomodulation up-regulates cytoprotective enzymes in the P23H retina.
Photoreceptor cell death by mitochondrial dysfunction, generation of reactive oxygen
species and apoptosis are common in human retinal dystrophies and degenerations and
light-induced retinal degeneration in animal models (Carmody and Cotter 2000). (Stone,
Maslim et al. 1999). NIR-PBM not only increases cytochrome oxidase activity and
oxidative capacity in the photoreceptors but also increases the concentrations of a critical
neuroprotective factor in the retina, the mitochondrial form of superoxide dismutase,
MnSOD (Figure 19). Overexpression of MnSOD in the retina has been shown to protect
the retina against oxidative damage (Kanwar, Chan et al. 2007). Early AMD like
characteristics are manifested in animal models with reduced retinal expression of
MnSOD.

Figure 19 NIR PBM upregulates mitochondrial form of superoxide dismutase,
MnSOD, in the inner segments, which can protect the degenerating retina from
oxidative damage.

45

In summary, these preliminary data demonstrated that NIR-PBM treatment administered
once per day for 5 days during the critical period of photoreceptor cell loss (p10-p25) in
the P23H-3 rat increases retinal mitochondrial cytochrome oxidase activity, up regulates
the production of antioxidant protective enzymes and attenuates apoptotic photoreceptor
cell death.
These preliminary data obtained in collaboration with Diana Kirk, Krisztina Valter, Ph.D,
and Jonathan Stone, Ph.D. (Australian National University and Sydney University)
support our hypothesis and set the stage for more detailed studies described below.

SPECIFIC AIMS, RATIONALE AND DESIGN
Specific Aim 1: To investigate the effect of NIR photobiomodulation in a nondystrophic (SD) animal.

Specific Aim 2: To determine if NIR photobiomodulation can protect
photoreceptors against damage induced by the P23H transgene and compare the
efficacy of 670 nm vs. 830 nm PBM using three different treatment protocols.
Three NIR-LED treatment paradigms will be tested.
a) The first treatment protocol will determine if NIR PBM can rescue photoreceptor
function during the critical period of photoreceptor development. In these studies,
immature P23H rats will be treated once per day with 670 nm-LED or 830 nm-LED
(4 J/cm2) during the critical period (p10-25). Retinal function (mixed and cone
electroretinography responses), in vivo retinal imaging and histomorphometric
analysis will be determined at p30.
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b) In the second treatment protocol, immature P23H rats will be treated once per day
with 670 nm or 830 nm -LED (4 J/cm2) from the onset of the critical period of
photoreceptor cell death to young adulthood (p10-p40). The efficacy of NIR PBM
will be assessed at p45 by measurement of retinal function, in vivo retinal imaging
and photoreceptor cell loss as above. These studies will determine if a longer
treatment protocol will improve photoreceptor protection and retinal function
compared with a limited treatment protocol.
c) In the third treatment protocol, we will determine if photobiomodulation can rescue
remaining photoreceptors and preserve retinal function in young adult rats in which
the majority of rods have degenerated. For these studies young adult P23H rats (P20)
will be treated once per day with 670 or 830 nm nm-LED (4 J/cm2) from p20 to p40
and we will examine the efficacy of photobiomodulation at p50 as described above.
Rationale and design for Specific aim 2: The P23H rhodopsin transgenic rat is a model
of autosomal dominant retinitis pigmentosa in which photoreceptor degeneration
especially the rod degeneration begins as early as p10. The ONL thickness decreases
from approximately 46µm from p10 to 22µm by p25 which is considered as the critical
period of photoreceptor degeneration in this model (Yu, Cringle et al. 2004). Rod
degeneration is nearly complete by p60. The first two experimental designs will
investigate the therapeutic potential of NIR-PBM during the critical period (p10-p25) and
from critical period to young adulthood (p10-p40). The third design will investigate the
potential of NIR-PBM to rescue remaining photoreceptors and preserve retinal function
after the majority of rods have degenerated.
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Specific Aim 3: To investigate the cellular changes underlying the protection
provided by NIR photobiomodulation.

These studies will test the hypothesis that NIR-PBM will stimulate photoreceptor
bioenergetics by up regulating retinal cytochrome oxidase expression and will also up
regulate antioxidant protective pathways and neuroprotective factor production.
The experiments described in specific aim 2 will characterize the effects of NIR-PBM on
RP. The functional biochemical and molecular studies will provide information on the
mechanism(s) by which NIR-PBM protects retinal function. These experiments are
fundamental in determining the potential of NIR-PBM as a therapeutic approach in the
prevention and treatment of retinal dystrophies and retinal degenerative disease. The
results of this research may provide the essential information required to initiate an
investigation into the clinical use of NIR-PBM as an innovative and noninvasive
therapeutic approach.
Rationale and design for specific aim 3: Oxidative stress and mitochondrial dysfunction
play vital roles in the pathogenesis of photoreceptor cell death in retinal degeneration.
These studies will test the hypothesis that NIR-PBM will improve mitochondrial function
and attenuate oxidative stress in the P23H rat.
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CHAPTER 3
MATERIALS AND METHODS
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ANIMAL MODEL
All animal experiments have been approved by the Institutional Animal Care and Use
Committee (IACUC) and were conducted in accordance with the ARVO (The
Association for Research in Vision and Ophthalmology) statement for the use of animals
in ophthalmic and vision research and with the National Institutes of Health regulations.
Heterozygous P23H transgenic rats, the offspring of P23H homozygotes and SpragueDawley (SD) albino rats (Harlan Sprague Dawley, Madison, WI) were used as the model
of retinal degeneration. The original P23H homozygotes were obtained from Retinal
Degeneration Rat Model Resource at University of California, San Francisco.
This model was selected for the following reasons:
(1) It is a widely studied model of retinal dystrophy, allowing us to integrate and
compare our findings with those of other investigators (Walsh, van Driel et al. 2004)
(Yu, Cringle et al. 2004) (Machida, Kondo et al. 2000).
(2) Several neuroprotective strategies have been investigated in the P23H rat, facilitating
a comparison with the efficacy of PBM (Leonard, Petrin et al. 2007) (LaVail,
Yasumura et al. 2000)
(3) The time course of photoreceptor degeneration in the P23H rat is relatively short,
enabling us to evaluate the efficacy of photobiomodulation within a few months and
to modify treatment protocols depending on our findings.
Housing conditions and light management
All animals were bred and housed in an American Association for Accreditation of
Laboratory Animal Care (AAALAC) approved animal facility at the University of
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Wisconsin-Milwaukee. Animals were supplied food and water ad libitum and maintained
in a temperature and humidity-controlled environment under dim cyclic light, 12-hour
light/12-hour dark cycle, with an average illuminance of 5 to 10 lux inside the cage.

NIR LIGHT EMITTING DIODE ARRAY AND TREATMENT
PROTOCOL
A monolithic array of custom fabricated (λ=670nm and λ=830nm) Light Emitting Diodes
(LED) engineered to eliminate heat (Hybrid GaAlAs, Quantum Devices, Inc., Barneveld,
WI) and designed to emit diffused monochromatic light at specific wavelength of photon
energy were used to deliver light at a desired energy density. The LEDs are shielded by a
glass barrier and are unlensed, allowing for even dispersion of light over a 180° viewing
angle (Figure 20). This allows each LED chip to act as a point source, providing a high
degree of illumination uniformity. The hybrid lamp housing contains the ceramic
substrates on which LED arrays are assembled, acting as a heat sink. A fan is mounted on
the opposite side of the light source to keep the monolithic system running cool. The
LED arrays are factory calibrated for proper LED wavelength and intensity before use.
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Figure 20 LED arrays used for delivering NIR photons. WARP 75 LED Unit
2

(Left); λ = 670 ± 20 nm; Surface Energy: 60mW/cm ; Fluence ~5.4J /cm2 .
SpectraLife LED Hybrid Lamp (Right); λ=830nm ± 10 nm; Surface Energy:
2

50mW/ cm2 ; Fluence ~4.5 J/cm

Immature and young adult P23H-1 transgenic rats were hand-held by the investigator or
placed in a plexiglass restraint device and the WARP 75 or SpectraLife LED Hybrid
Lamp were positioned directly over the animal’s head at a distance of 2 cm exposing both
eyes (Figure 21). Sham-treated SD rats were handled in the same way, except that they
were not exposed to the LED array. These treatment protocols have been used with both
immature and adult rodents and are well tolerated by the animals. Treatment consisted of
irradiation at 670 nm for 90 sec at a power intensity of 50mW/cm2, resulting in an energy
density of 4.5 joules/cm2 at the surface of the cornea or irradiation at 830 nm for 180 sec
at a power intensity of 25mW/cm2, resulting in an energy density of 4.5 joules/cm2 at the
surface of the cornea. These stimulation parameters have been previously demonstrated
to stimulate cell survival and cytochrome oxidase activity in cultured neurons, to promote
wound healing clinically and in experimental animal models to promote the survival and
functional recovery of the retina and optic nerve in vivo after acute injury by a
mitochondrial toxin and to exhibit neuroprotective actions in the retinae of P23H rats
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(Liang, Whelan et al. 2006) (Ying, Liang et al. 2008) (Desmet, Paz et al. 2006) (Whelan,
Buchmann et al. 2003) (Eells, Henry et al. 2003).

Figure 21 Exposure of animals to NIR photons. Animals were habituated to the
restraint apparatus and handling from p5. Monochromatic LED source is placed
directly over the animal’s head at a distance of 2 cm exposing both eyes.

ASSESMENT OF STATUS OF RETINA
To evaluate the therapeutic efficacy of 670 nm and 830 nm PBM, the status of the retinae
was assessed by measuring well established indices of photoreceptor function,
photoreceptor morphology and by a new measurement of retinal oxidative metabolism

53

Photoreceptor function will be assessed by
Full-Field Flash Electroretinography
Animal preparation
The function of the retina was monitored using full-field flash electroretinography
(ERG), which measures the electrical impulses emitted by the retina in response to
flashes of light. Animals were dark adapted for at least 2 hours prior to recording and
were prepared under red dim light. Animals were anesthetized with an intraperitoneal
injection of xylazine- ketamine hydrochloride cocktail (5 mg/kg and 100 mg/kg
respectively). Pupils were dilated with 0.1% atropine and mild topical anesthesia was
applied on the eyes.

Animals were placed on a heating pad to maintain the body

temperature at 37°C during the entire recording time. Full-field ERGs were obtained
using Handheld Multi-species ElectroRetinoGraph (HMsERG) Instrument (Retvet Corp,
MO).
Photostimulator
The Mini-Ganzfeld half-sphere bowl is 76 mm in diameter, and has a 55 mm circular
aperture (Figure 23). This is illuminated with white LEDs, which have a rated color
temperature of around 70000 K and flash intensities ranging from 10 mcd.s/m2 to 30
cd.s/m2. Flash intensity is set by a combination of flash time (from 5 microseconds to 5
milliseconds) and LED peak current. The white light flash intensity in the Ganzfeld dome
is protocol dependent. The individual tests set the flash intensity from 10 mcd.s/m2 to
25000

cd.s/m2 and the flash duration runs from 0.005 to 5 msec. Any required
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background illumination can also be set. The photostimulator is intended to be used
close to the animal’s eye (between 1 and 2cm).
Placement of electrodes and ERG recording
A nylon coated gold thread electrode was placed on the corneal surface, overlaid with 1%
methylcellulose and a small drop of methylcellulose was placed into the concave side of
the contact lens before it was placed over the thread electrode. The corneal contact lens
will be adjusted so that it was centered on the retina. Stainless steel needle ground
electrode was inserted on top of the head (midline). Stainless steel needle reference
electrodes were inserted subcutaneously on either side of the base of the ear. Needle
electrodes were secured with surgical tape (Figure 22). Signals obtained from the corneal
surface were amplified, digitized and averaged using ERG view 2.5 software (Retvet
Corp, MO). This software allows for low pass filtering of the final ERG test waveforms
before they are graphed on the unit. This filter can be used to remove environmental and
unit generated noise from the observed ERG. A custom designed Faraday cage was
employed block 60 cycle electrical noise. The amplitudes and latencies of the a-waves
(photoreceptor responses,) and b-waves (bipolar cell and Muller cell responses) were fit
to a computational model to determine transduction parameters for photoreceptor
responses(Figure 24 & 25).
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Figure 22 Animals were dark-adapted, anesthetized, pupils dilated and placed on
a thermoregulated heating pad at 37°C during recordings.

Figure 23 Full-field ERGs were obtained in a Mini-Ganzfeld half-sphere bowl.
Flash intensities are generated with white LEDs and duration of the each flash is
test dependent.
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Figure 24 A normal biphasic ERG waveform showing a-wave and b-wave
amplitude
and
corresponding
implicit
times.
Reproduced
from
www.webvision.med.utah.edu. The a-wave reflects the physiological activity in
the photoreceptors of the outer retina and the b-wave corresponds to the electrical
responses from the inner retinal layers including the ON bipolar cells and the
Muller cells (Miller and Dowling 1970).

Figure 25 Comparison of a-wave and b-wave amplitude obtained from a normal
subject (left) and from a patient with RP. Reproduced from
www.webvision.med.utah.edu
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Due to the high number of rods in the rodent retina compared to cones, the ERG response
following a white flash of light is predominantly the rod photoreceptor response. The
flash intensity, number of flashes and its rate and the exposure time can be manipulated
so that the rod and cone photoreceptor function can be isolated. Two well established
protocols are used in this dissertation.
Scotopic intensity series protocol
This protocol gives the best estimate of the functional status of the retina using increasing
flash intensities over a fixed time period (Table 1). The resulting scotopic intensity
response curves were plotted and compared between treated and sham control animals.

Action
Test 1
Delay
Test 2
Delay
Test 3
Delay
Test 4
Delay
Test 5
Delay
Test 6
Delay

Flash intensity

Interval
seconds

mcd.s/m2
100

Number
of flashes
Avg’d
4

-1

300

4

10

-0.5

1000

4

10

0

3000

4

10

0.5

10000

1

Log
-1.5

10

Action
time
Seconds
40
60
40
60
40
60
40
60
60

~1.0

25000

Total Time Elapsed in
Minutes

1

Elapsed
Time
Seconds
40
100
140
200
240
300
340
400
400
460
460
7.7

Table 1 Protocol for scotopic intensity series electroretinography (Reproduced
and modified from HMsERG user manual).
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International Society for Clinical Electrophysiology of Vision (ISCEV) protocol
To tease out individual and combination of photoreceptor response, ISCEV
recommended protocol is used (Table 2). Varying the flash intensity, duration and rate of
stimulation after dark adaptation and background adaptation (with 30000 mcd.s/m2
intensity for 10 minutes) will help to isolate rod response as well as cone photoreceptor
response.

ERG test
Session

Flash intensity
Log
mcd.s/m2

Dark
Adaptation
Rods
Delay
Std.Rods &
Cones
Delay
Hi.Int.Rods
& Cones
BG
adaptation
Cones with
BG
Delay w/BG
Hi Cones
with BG
Delay with
BG
Std.Flicker
w/BG
Delay with
BG
Hi.Int.
Flicker
w/BG

Number Interval
Action
of
seconds
time
flashes
Seconds
Avg’d
ISCEV recommends 20 Minutes

-2.5

10

10
4

0

3000

0.5

10000

1

30000

0

3000

32

0.5

10000

32

2
2
10

18
2
30

18
20
50

20

30
60

80
140

600

740

0.5

15.5

755.5

0.5

2
15.5

757.5
771

2

773

4.192

777.2

2

779.2

4.192

783.4

4

0

0.5

3000

10000

128

128

Total time elapsed in Minutes

Elapsed
Time
Seconds

0.032

0.032

13.06

Table 2 ISCEV protocol for electroretinography. The animals are dark adapted for
20 minutes before the procedure. The ISCEV protocol includes 7 standardized
individual tests as recommended by the ISCEV (Reproduced and modified from
HMsERG user manual).
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Retinal Morphology will be assessed by
Spectral Domain Optical Coherence Tomography (SD-OCT) imaging
Optical coherence tomography is a non-invasive optical imaging technique that uses low
coherence interferometry to create high resolution, cross-sectional, two and three
dimensional tomograms of biological tissue in vivo (Drexler, Morgner et al. 2001). OCT
is extensively used in ophthalmology to understand retinal and corneal morphology to
help early diagnosis and detection of ocular pathologies, when treatment is most
promising. Specific advantages of OCT include excellent depth (axial) and lateral
resolution, which allows finer anatomical details of the retina to be observed (Figure 26).

Figure 26 Set up of an OCT system for retinal imaging. The light source is
typically a broad band source and the light (λ~ 800nm) is split into half by a beam
splitter and sent to a reference arm and the sample arm. The backscattered light is
reflected back from the sample arm and reference arm combines forming an
interference pattern. This spectrum is detected via a spectrometer placed as the
detector and an algorithm is used to reconstruct an A –scan which represents the
anatomical features of retina. Multiple A-scans are used to generate B-scan and
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multiple B-scans are used to generate 3D volume scans. (Reproduced and
modified from Frohman, Fujimoto et al. 2008).
Animal Imaging Mount and Rodent Alignment System
Before the animal is anesthetized for imaging, the Animal Imaging Mount (AIM) and
Rodent Alignment System (RAS) are aligned with the long axis of animal cassette with
laser. Once the long axis of the laser and the cassette are along the same z-axis, an aiming
tip is placed at the end of the bore and adjustments are made to achieve the “Magic
Point” for aiming. The “Magic Point” is referred to as the intersection of 3 axes which are
Cassette center line, Optical axis of the imaging probe and the Cassette swivel axis
(Figure 27).

Figure 27 Aligning the AIM-RAS to achieve the “Magic Point” for aiming (Reproduced
and modified from Bioptigen’s Guide to Small Animal Imaging: Optimizing Image
Quality presentation by Joseph Vance).
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Animal preparation
Animals were anesthetized by an intraperitoneal injection with a ketamine and xylazine
mixture (50:5 mg/kg body weight) and the pupils are dialated with 1% atropine sulphate
ophthalmic solution. After one minute hydrate the cornea with sterile Systane Ultra
Lubricant Eye Drops (Polyethylene Glycol 400, 0.4% and Propylene Glycol 0.3%; Alcon
Labs). Systane Ultra offers the right balance of viscosity and optical properties, and the
corneal surface is hydrated every 2 minutes during the entire period of anesthesia to
prevent dryness and opacities arising from exposure keratopathy. Lubricant is wicked
away before acquiring an image to have high image quality. Both eyes were imaged in a
single session by mounting the animal with a bite bar on a custom made six-axis rodent
alignment system. The bite bar is laterally and ventrally adjusted to align the animal eye
with the “Magic Point” for aiming (Figure 28).

Figure 28 Animal Imaging Mount and Rodent Alignment System with bite bar.
The bite bar helps to reproduce alignment of the rodent eye and suppress motion
artifacts from breathing.
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The fundus imaging camera in the animal imaging mount provided initial alignment for
the light source during the real time aiming. The Optic Nerve Head (ONH) will be used
as a landmark and the alignment of the OCT optics with the retina usually is done with a
‘Fast Fundus’ scan (200x100x1.6x1.6x1x1). This scanning allows the user to get realtime feedback on the location from volume intensity projection (VIP) as user adjusts the
cassette. After positioning the ONH, aiming mode was used to adjust the image
brightness and contrast. Two linear scans at1000x80x1 (0 degree and 90 degree) and 2
volume scans at 750x250x1x1 (0 degree and 90 degree) per eye were captured and saved
using the Bioptigen's InVivoVueTM software. The linear scans were exported from the
OCT machine and read into ImageJ (http://www.rsb.info.nih.gov/ij/) for processing. A
rigid body registration is performed using the ImageJ plug-in “StackReg”. The frames
that have motion artifacts were removed subjectively before averaging to prevent
surrounding frames from causing distortion. Averaging also removes large amount of
speckle noise contained in individual OCT scans. The averaged scans from P23H and SD
animals were used for segmentation of retinal layers for total retinal thickness (Figure 29)
using algorithm generated in MATLAB (Mathworks, Natick, Massachusetts, USA).
100px

Figure 29 Representative image (line scans 1000x80x1samplings) centered on the
ONH, showing the segmentation lines for automated segmentation for Total
Retinal Thickness. 100 pixels (px) are removed at the ONH manually to account
for variable thickness in this region.
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Automated segmentation generates retinal thickness over the entire B-scan and a 100
pixel correction was used in the final average thickness to account for variable thickness
in this region. The difference in reflectivity of retinal layers was explored in generating
longitudinal reflectivity profiles (LRP) (Figure 30) for individual layers from the
averaged scans using ImageJ at fixed locations from the 100 pixel area as demonstrated
in Figure 31.

Figure 30 Longitudinal Reflectivity Profile (LRP) and the corresponding individual
retinal layers (Nerve Fiber Layer; NFL & Ganglion Cell Layer; GCL, Outer Plexiform
Layer; OPL, Outer Nuclear Layer; ONL, Inner Segment/Outer Segment; IS/OS, Retinal
Pigment Epithelium; RPE and Choroid)

Figure 31 Method used to generate spider plots for ONL thickness from averaged OCT
scans.
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Quantitative Morphometric Analysis: Measurement of ONL thickness
ONL thickness was measured as previously described (Komeima, Rogers et al. 2007) . At
the defined time points, animals were euthanized with an overdose of sodium
pentobarbital (>60 mg/kg, intraperitoneal). One eye from each animal was prepared for
histological and immunohistochemical evaluation. The retina dissected from the other
eye was collected in Trizol for molecular analysis. The eyes for histology and
immunohistochemistry were marked at the superior position (in the corneal limbus) using
a surgical cautery and eyes were removed and embedded either in paraffin, plastic or
optimal cutting temperature compound (Tissue-Tek OCT Compound ,Sakura Finetek
USA , Inc.) depending upon the parameters investigated. The Ten-micrometer sections
will be cut perpendicular to the 12:00 meridian through the optic nerve. The sections
were stained with Harris hematoxylin and eosin (Fisher Scientific, Pittsburgh, PA),
Toluidine blue and was placed in mounting medium and examined with a Olympus
Axioskop microscope (40x objective). The images were digitalized and analyzed with
ImageJ by outlining the ONL and then measuring the ONL thickness at three locations
(100 µm, 200 µm and 300 µm) on the superior pole of the optic nerve and three locations
(100 µm, 200 µm and 300 µm) on the inferior pole of the optic nerve as described (Usui,
Komeima et al. 2009).
Photoreceptor protection was assessed by
Measurement of Surviving photoreceptors: The number of surviving photoreceptors
was quantified by the thickness of the ONL and by counting the rows of nuclei in
Toluidine blue stained resin sections, and a comparison analysis was made with the
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SDOCT images at the same location. The number of cells observed in the outer nuclear
layer (ONL), inner nuclear layer (INL) and ganglion cell layer (GCL) were counted and
recorded separately for each 1mm distance from the ONH and a spider graph was plotted.

Experimental Design and Methodology for Aim 2: To investigate the effect of PBM
on mitochondrial function in the P23H retina.
Retinal metabolic state was assessed by Cryo Optical Imaging
Fluorescence imaging provides specific information on tissue using intrinsic fluorophores
or exogenous tagged proteins. Since some of the molecules in the cell act as intrinsic
fluorophores and are able to fluoresce when excited with the appropriate wavelength, a
growing field of fluorescence microscopy techniques relies on autofluorescent
fluorophores. Fluorescence-based techniques are widely used in biomedical applications
as diagnostic tools for early detection of various diseases such as cancers or heart disease
(Ranji, Jaggard et al. 2006). Optical fluorescence techniques have the potential to
diagnose tissue metabolic states in intact organs. These techniques are widely used in
biomedical applications and have been shown to have a high sensitivity and specificity
for discriminating between diseased and non-diseased tissue (Richards-Kortum, Mitchell
et al. 1994) (Wagnieres, Star et al. 1998).
Oxidative phosphorylation in the mitochondria provides photoreceptors with adequate
amounts of ATP for the high energy demanding phototransduction process, and
mitochondrial metabolic coenzymes Nicotinamide Adenine Dinucleotide (NADH), and
Flavin Adenine Dinocleotide (FADH2) are the primary electron carriers in oxidative
phosphorylation. NADH and FAD (the oxidized form of FADH2) are autofluorescent and
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can be monitored without exogenous labels through the use of optical techniques. These
coenzymes are beneficial in that NADH is primarily fluorescent in its reduced
biochemical state, whereas FAD is only fluorescent in its oxidized form. Therefore, by
imaging these two coenzymes, we can probe the oxidative state of the metabolism in
tissue. The fluorescent signals of these intrinsic fluorophores have been used as indicators
of tissue metabolism in injuries due to hypoxia, ischemia, and cell death (Ranji,
Kanemoto et al. 2006). The normalized ratio of these fluorophores, (NADH/FAD), called
the NADH redox ratio (NADH RR), acts as a novel marker of the mitochondrial redox
and metabolic state of tissue ex vivo and in vivo (Maleki, Sepehr et al. 2012).

Sample Preparation: Freezing and embedding
The rats were sacrificed, and their eyes were harvested and frozen rapidly for low
temperature cryoimaging. The eyes were embedded in a black mounting medium as
shown in Figure 32 and scanned by the cryoimager in 500 slices each 10 µm apart
through the whole eye.

a

b

Figure 32 (a) frozen eye and b) embedding frozen eye in customized mounting
medium.
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Calibration
A calibration method was designed to compensate for day-to-day variation of light
intensity and non-uniformity of the illumination pattern. At the beginning of each
experiment and before slicing the tissue, a uniform fluorescent flat plate was placed in the
same position as tissue and imaged in all channels to acquire the illumination pattern.
Since the fluorescence of the standard is in both the NADH and FAD channels, it also
accounts for day-to-day light intensity and uniformity changes in all channels. All the
images in each channel were then normalized by dividing each image to the flat plate
image, captured in the same channel.
Cryoimager
Figure 33 shows the schematic for the 3D cryoimager used in this study. The cryoimager
is an automated image acquisition and analysis system consisting of software and
hardware designed to acquire fluorescence images of tissue sections. A motor-driven
microtome sequentially sections frozen tissue at the desired slice thickness while filtered
light from a mercury arc lamp excites up to five distinct fluorophores in the exposed
surface of the tissue block. The excitation light source is a 200W mercury arc lamp
filtered at the excitation wavelengths of NADH and FAD, 336 nm and 470 nm,
respectively. The emission wavelengths are 520 nm and 450 nm for FAD and NADH,
respectively. At each slice, a CCD camera records fluorescence images of the tissue
block in pixel dimensions of 10 µm × 10 µm to be later analyzed for fluorophore
distribution. The microtome is housed in a freezer unit that maintains the sample at -80°C
during sample slicing and image acquisition. The resolution in the z direction of
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microtome slices can be as small as 5 um. For this study, we used a resolution of 10 um
in the z direction, which resulted in ~ 400 z-slices per eye.

Figure 33 Schematic representation of a Cryoimager. This device sequentially
slices the tissue, imaging the surface between each successive slice, in as many as
5 channels. The images are then displayed and saved to a computer, where they
can be processed to create a 3-D rendering of the tissue.

Data analysis
FAD and NADH autofluorescence images (containing 250 slices per eye) from each
group of eyes were processed using Matlab. The composite images were created using all
the image slices for each eye, for both NADH and FAD signals. The ratio of NADH and
FAD, known as the NADH redox ratio (Sepehr, Staniszewski et al. 2012), was calculated
voxel by voxel, using Matlab, according to equation (1).
Redox Ratio = RR = NADH / FAD

(1)

69

The 2D representation of each eye was then calculated using the maximum intensities in
the z axis of the NADH redox 3D volume (max projection). In the maximum projection
method, first a full 3D volume of images was obtained, including RR, and then the
maximum projection on the volumetric data was performed and the histograms were
plotted for this maximum projection. The maximum projection is used since the entirety
of the anatomy has a significant contribution in this representation. A histogram of the
max projection of RR values in each group was created, and the mean (or first moment)
of this histogram was calculated according to Eq. (2).

1
Mean 
Nx  N y

Nx Ny

 eye _ Maxpro(i, j)

(2)

i 1 j 1

Where Nx and Ny are the number of pixels in the x and y directions and the pixel size in
x and y is 10μm and 10μm. The previously mentioned histograms were calculated for
quantitative comparison between normal and diseased groups.
Statistical Analysis
Sample size for the experiment will be determined by power analysis. The data obtained
from the study will be analyzed using SPSS. All values will be expressed as means ±
SEM. A mixed model ANOVA (Greenhouse-Geisser correction was performed whenever
the assumption of sphericity was violated), MANOVA, 1-way ANOVA (Kruskal-Wallis
test) and Student's t-test performed, as appropriate. Statistical analysis was performed
using SPSS 19.0 (SPSS Inc, Chicago, IL) and GraphPad Prism 4.0 (GraphPad, La Jolla,
CA USA). The level of significance for all statistical tests was set at 0.05
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CHAPTER 4
EFFECT OF NIR PHOTOBIOMODULATION IN NON DYSTROPHIC ANIMAL MODEL
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Many studies with PBM have shown that in the absence of pathology, there is no
physiological action of the light. Moreover, our previous studies on methanol and light
induced toxicity models of retinal degeneration demonstrated the lack of any significant
effect of NIR treatment on normal, healthy and non-challenged retinal physiology. Natoli
et al. (2010) demonstrated by wide-scale gene analysis that NIR treatment resulted in the
up regulation of many noncoding RNAs (ncRNA) (Natoli, Zhu et al. 2010). The inability
of ncRNAs to translate to a functional protein may explain the cellular effects of NIR
PBM in a non-dystrophic retina. Follow up studies are needed to characterize the exact
role of these ncRNAs in the mammalian retina. Albarracin et al. suggested a possible
hypothesis that the up regulated ncRNAs in the above animal models following NIR
PBM may not have any significant function in the healthy retinal cellular environment
but may be acting as a pre-conditioning event in the retina leading to altered regulation of
potentially damaging genes in the presence of stress stimuli, as seen in induced or
inherited retinal degenerations (Albarracin, Eells et al. 2011).
Studies were performed to characterize the role of NIR-PBM during the early phase of
photoreceptor development in non-dystrophic SD animal at both 830 nm and 670 nm.

830 nm photobiomodulation does not alter retinal function in non-dystrophic SD
rats.
Figure 34 and Figure 35 summarizes the average a-wave and b-wave amplitudes
measured by dark-adapted full-field flash ERG using the scotopic intensity series
protocol. In agreement with the previously published data from our lab and other
colleagues 830 nm PBM in a non-challenged retina does not alter retinal function.

72

The main effect of mean ERG amplitudes between non-dystrophic SD and 830nm treated
non-dystrophic SD rats for a-wave (F(1,14) = .627, p = .442; Figure 34 ) and for b-wave
(F(1,14) = .122, p = .733 ; Figure 35 ).

Figure 34 shows the comparison of mean a-wave amplitude between SD normal
control (■; n=8) and 830nm treated SD normal control (▲; n=8) groups. The awave represents the functional electrical activity recorded from the photoreceptors
and reflects the general health of the photoreceptor layer of the retina. The main
effect between groups were not statistically significant (F(1,14) = .627, p = .442)
between groups at various flash intensities. Error bars: SEM.
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Figure 35 shows the comparison of mean b-wave amplitude between SD normal
control (■; n=8) and 830nm treated SD normal control (▲; n=8) groups. The bwave represents the functional electrical activity post synaptic to photoreceptors
and reflects the health of the inner layers of the retina. The main effect between
groups were not statistically significant (F(1,14) = .122, p = .733) between groups at
various flash intensities. Error bars: SEM.

Figure 36 and figure 37 summarize the mean a- wave and b- wave implicit times for the
above scotopic intensity series protocol.
The main effect of mean ERG implicit times between non-dystrophic SD and 830nm
treated non-dystrophic SD rats for a-wave (F(1,14) = 1.14 , p = .302; Figure 36 ) and for bwave (F(1,14) = 4 .12, p = .062 ; Figure 37).
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Figure 36 shows the mean a-wave implicit time comparing SD normal control (■;
n=8) and 830nm treated SD normal control (▲; n=8) groups. The a-wave implicit
time represent s the time from flash onset to the trough of the a-wave. There was
no significant difference (F(1,14) = 1.14 , p = .302) between groups at various flash
intensities. Error bars: SEM

Figure 37 shows the mean b-wave implicit time comparing SD normal control (■;
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n=8) and 830nm treated SD normal control (▲; n=8) groups. The b-wave implicit
time represents the time from flash onset to the peak of the b-wave. There was no
significant difference (F(1,14) = 4 .12, p = .062) between groups at various flash
intensities. Error bars: SEM

670 nm photobiomodulation does not alter the retinal function and retinal
morphology in non-dystrophic SD animal.
Figure 38 and figure 39 show the average a-wave and b-wave amplitudes assessed by
dark-adapted full-field flash ERG using scotopic intensity series protocol comparing nondystrophic SD and 670nm light treated non-dystrophic SD rats. Similar to our findings
with 830 nm PBM, 670 nm PBM did not alter retinal function or retinal morphology in
the non-dystrophic retina.
The main effect of mean ERG amplitudes between non-dystrophic SD and 670 nm
treated non-dystrophic SD rats for a-wave (F(1,10) = .039, p = .848; Figure 38 ) and for bwave (F(1,12) = .147, p = .708 ; Figure 39).
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Figure 38 shows the comparison of mean a-wave amplitude between SD normal
control (■; n=6) and 670 nm treated SD normal control (▲; n=8) groups. The awave represents the functional electrical activity recorded from the photoreceptors
and reflects the general health of the photoreceptor layer of the retina. The main
effect between groups were not statistically significant (F(1,10) = .039, p = .848)
between groups at various flash intensities. Error bars: SEM
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Figure 39 shows the comparison of mean b-wave amplitude between SD normal
control (■; n=8) and 670 nm treated SD normal control (▲; n=6) groups. The bwave represents the functional electrical activity post synaptic to photoreceptors
and reflects the health of the inner layers of the retina. The main effect between
groups were not statistically significant (F(1,12) = .147, p = .708) between groups at
various flash intensities. Error bars: SEM.

Figure 40 and Figure 41 summarize the mean a- wave and b- wave implicit times for
the above scotopic intensity series protocol .
The main effect of mean ERG implicit times between non-dystrophic SD and 670 nm
light treated non-dystrophic SD rats for a-wave (F(1,14) = .103. , p = .752; Figure 40) and
for b-wave (F(1,14) = 2.31, p = .151 ; Figure 41)
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Figure 40 shows the mean a-wave implicit tine comparing SD normal control (■;
n=8) and 670 nm treated SD normal control (▲; n=8) groups. The a-wave
implicit time represent s the time from flash onset to the trough of the a-wave.
The main effect between groups were not statistically significant (F(1,14) = .103. , p
= .752) at various flash intensities. Error bars: SEM.

Figure 41 shows the mean b-wave implicit time comparing SD normal control (■;
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n=8) and 670 nm treated SD normal control (▲; n=8) groups. The b-wave
implicit time represents the time from flash onset to the peak of the b-wave. There
was no significant difference (F(1,14) = 2.31, p = .151) between groups at various
flash intensities. Error bars: SEM
Total retinal thickness was quantified in non-dystrophic SD and 670 nm light treated nondystrophic SD rats using SD-OCT and the mean total retinal thickness (Figure 42) was
not significantly different between the groups (SD: 174.2 ± 2.3 µm, n=4 vs. SD-670:
181.0 ± 2.4 µm, p<.05)

SD

AVG_P10-P25-SD1_OD_L_2_0_OOOOOO2

SD-670nm

AVG_P10-P25-SD3_670nm_OD_L_2_0_OOOOOO2
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Figure 42 shows the average total retinal thickness (upper panel) generated from
SD-OCT linear scans (n=4) between non-dystrophic SD animals and 670 nm
treated SD animals. Lower panel shows the representative linear scans at the same
location on the retina (ONH used as the landmark) comparing non-dystrophic SD
animal and 670 nm treated SD animal and there was no significant difference in
the retinal morphology or structural integrity of retina following 670 nm NIRPBM. Error bars: SEM

In summary 830 nm and 670 nm photobiomodulation did not alter the functional
response or the structural integrity of retina in a non-dystrophic control animal. These
findings are important with respect to both animal and human safety considerations. This
is a crucial piece of evidence for a comprehensive FDA approval for the use of NIR-LED
devices in control populations in clinical trials for the treatment of retinal degenerative
diseases.
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CHAPTER 5
MITOCHONDRIAL REDOX IMAGING

[This Chapter is submitted to be considered for publication in the Journal of Biomedical
Optics and the authors assign(s) to Society of Photo-Optical Instrumentation Engineers
(SPIE) copyright ownership in the work presented in this Chapter, effective if and when
the Paper is accepted for publication by SPIE and to the extent transferable under
applicable national law]
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Introduction
Irreversible loss of rod photoreceptors is the outcome of abnormal physiology
associated with mutated or absent gene products and leads to blindness in many retinal
degenerative disorders, including retinitis pigmentosa (RP). RP is a large genetically
heterogeneous group of inherited retinal degeneration characterized by progressive and
neurodegenerative photoreceptor apoptosis with subsequent degeneration of the cone
photoreceptors and the retinal pigment epithelium (RPE) cells (Besch, Jagle et al. 2003;
Sancho-Pelluz, Arango-Gonzalez et al. 2008). RP is the leading cause of inherited retinal
degeneration-associated blindness in the developed world (Hartong, Berson et al. 2006).
To date 52 genes are known to be associated with all forms of RP inheritance (Neveling,
Collin et al. 2012). Although the majority of RP cases are monogenic, the disease is
characterized by its genetic heterogeneity and approximately 10% of the RP cases are due
to defects in rhodopsin (RHO) gene (Dryja, McGee et al. 1990). The Pro23His (P23H)
rhodopsin mutation underlies the most common form of human autosomal dominant
retinitis pigmentosa (adRP). The symptoms of RP are well characterized and a prominent
early clinical feature of RP manifests as night blindness with peripheral visual field loss
as a result of the death of rod photoreceptor cells (Shigenaga, Hagen et al. 1994; Wallace
2005; Bramall, Wright et al. 2010).
Photoreceptors are the most metabolically active cells in the body. They contain a
dense concentration of mitochondria in their inner segments that provides the ATP for the
energy-intensive processes of outer segment renewal and maintenance of the dark current
(Bramall, Wright et al. 2010). The high metabolic demand in photoreceptors for
phototransduction processes is met by mitochondrial oxidative phosphorylation
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(OXPHOS). The retina is also adequately supplied with glucose and oxygen by the
choroidal vessels through the RPE cells. ATP is generated as a result of the synchronized
activity of tricarboxylic acid (TCA) cycle and the multi enzyme complex-electron
transport chain (ETC). The coenzymes, nicotine adenine dinucleotide (Karunadharma,
Nordgaard et al.) (Karunadharma, Nordgaard et al.) and flavin adenine dinucleotide
(FADH2) are electron carriers in the ETC. Between 0.4–4.0% of all oxygen consumed in
OXPHOS is transformed to superoxide (O2−) radicals (Shigenaga, Hagen et al. 1994)
which are converted to H2O2 by Mn superoxide dismutase (Wallace 2005) and finally to
molecular H2O by glutathione peroxidase (GPX) or peroxiredoxin III (PRX III) (Green,
Brand et al. 2004). However, the inability of the antioxidant systems (superoxide
dismutase, glutathione and thioredoxin systems) in the mitochondria to quench the
increased production of reactive oxygen species (Ranji, Kanemoto et al.) (Ranji,
Kanemoto et al.) creates a biochemical imbalance known as oxidative stress (OS),
resulting in oxidative damage to the mitochondrial proteins, lipids and DNA. This
oxidative damage initiates a cascade of events resulting in mitochondrial dysfunction and
cell death (Shigenaga, Hagen et al. 1994; Wallace 2005; Vlachantoni, Bramall et al.
2011). Considerable evidence supports a key role for mitochondrial dysfunction and
oxidative damage in the pathogenesis of progressive photoreceptor cell death by
apoptosis in RP both in vitro (Sanvicens, Gomez-Vicente et al. 2004; Sanz, Johnson et al.
2007) and in vivo (Donovan, Carmody et al. 2001; Yamada, Yamada et al. 2001; Sanz,
Johnson et al. 2007). Mitochondrial dysfunction and OS have also been documented in
other

retinal

degenerative

disorders

including

glaucoma,

age-related

macular

degeneration (AMD) and diabetic retinopathy, as well as, numerous neurodegenerative
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disorders including Parkinson’s disease and Alzheimer’s disease (Lin and Beal 2006;
Pieczenik and Neustadt 2007; Kong, Van Bergen et al. 2009; Karunadharma, Nordgaard
et al. 2010).
Optical fluorescence techniques have been shown to posses a high sensitivity and
specificity for discriminating between diseased and non-diseased tissue. Fluorescence
imaging provides specific information on tissue intrinsic fluorophores as a diagnostic tool
for early detection of different diseases (Ramanujam, Richards-Kortum et al. 2001; Ranji,
Kanemoto et al. 2006; Ranji, Matsubara et al. 2009; Maleki, Sepehr et al. 2012; Sepehr,
Staniszewski et al. 2012). Here we used optical fluorescence imaging to evaluate the
redox state of the P23H transgenic and the Sprague-Dawley (SD) normal retina.
Although a link between OS and photoreceptor degeneration has been proposed, a direct
analysis of the redox state within the mitochondrial compartment of the rodent eye has
not been performed. We hypothesized that there would be a significant difference in the
optical redox ratio of dystrophic retina of the P23H rat compared to that of the nondystrophic normal rat. We tested this hypothesis using a 3-D optical cryofluorescence
imaging technique.
Mitochondrial metabolic coenzymes NADH and FADH2 are two of the primary
electron donors and acceptors in OXPHOS, respectively. NADH and FAD (the oxidized
form of FADH2) are autofluorescent and can be monitored without exogenous labels
through the use of optical techniques. NADH is primarily fluorescent in its reduced
biochemical state, whereas FAD is only fluorescent in its oxidized form. Therefore, by
imaging these two coenzymes, we can probe the mitochondrial redox state of the tissue.
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Although this ratio is not a direct measure of the concentrations of these fluorophores, the
fluorescence intensity measured is a relative measure of their concentrations (Maleki,
Sepehr et al. 2012). The fluorescent signals of these intrinsic fluorophores have been used
as indicators of tissue metabolism in injuries due to hypoxia (Ranji, Kanemoto et al.
2006; Ranji, Matsubara et al. 2009; Maleki, Sepehr et al. 2012; Sepehr, Staniszewski et
al. 2012), ischemia (Ranji, Kanemoto et al. 2006; Ranji, Matsubara et al. 2009), and
diabetes (Maleki, Sepehr et al. 2012). Our studies have demonstrated that the ratio of
these fluorophores, (NADH/FAD), called the NADH redox ratio (NADH RR), acts as a
quantitative marker of the mitochondrial redox and metabolic state of tissue ex vivo
(Ranji, Jaggard et al. 2006) and in vivo (Matsubara, Ranji et al. 2010).
We evaluated the mitochondrial redox state quantitatively in the in situ retina
using a 3-D fluorescent optical imaging instrument called the cryoimager to detect the
oxidative state of the retina in P23H transgenic (diseased) eyes as well as SD normal eyes
Materials and Methods
Animal preparation:
All animal experiments were approved by the Institutional Animal Care and Use
Committee (IACUC) and were conducted in accordance with the ARVO (The
Association for Research in Vision and Ophthalmology) statement for the use of animals
in ophthalmic and vision research and with the National Institutes of Health regulations.
All animals were housed and bred in an American Association for Accreditation of
Laboratory Animal Care (AAALAC) approved animal facility at the University of
Wisconsin-Milwaukee.
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Albino SD normal and heterozygous P23H-1 transgenic rats, the offspring of
P23H-1 homozygotes (Retinal Degeneration Rat Model Resource, UCSF) and SD normal
albino rats (Harlan Laboratories, Madison) were fed ad libitum and maintained in a
temperature and humidity-controlled environment under dim cyclic light, 12-hour
light/12-hour dark cycle, with an average illuminance of 5 to 10 lux inside the cage.
Once animals reached P30, they were divided into two groups. The heterozygous P23H-1
rats were the model of retinal degeneration and SD normal albino rats were used as nondystrophic controls.
Electroretinogram Recording:
The function of the retina was monitored using full-field flash electroretinography
(ERG), which measures the electrical impulses emitted by the retina in response to
flashes of light. Animals were dark adapted for 2 hours prior to recording and were
prepared under red dim light. Animals were anesthetized with a xylazine/ketamine
cocktail (100 mg/kg and 5 mg/kg respectively, ip). Pupils were dilated with 0.1%
atropine and mild topical anesthesia (proparacaine 0.5%)

was applied to the eyes.

Animals were placed on a heating pad to maintain the body temperature at 37°C during
the entire recording period. A nylon coated gold thread electrode was placed on the
corneal surface, overlaid with 1% methylcellulose and a small drop of methylcellulose
was placed into the concave side of the contact lens before it was placed over the thread
electrode. The corneal contact lens was adjusted so that it was centered on the retina. A
stainless steel needle ground electrode was inserted on top of the head (midline).
Stainless steel needle reference electrodes were inserted subcutaneously on either side of
the base of the ear. Needle electrodes were secured with surgical tape. Signals obtained
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from the corneal surface were amplified, digitized and averaged using ERG view 2.5
software (Retvet Corp, MO). This software allows for low pass filtering of the final ERG
test waveforms before they are graphed on the unit. This filter can be used to remove
environmental and unit generated noise from the observed ERG. A custom designed
Faraday cage was employed to block 60 cycle electrical noise. The amplitudes and
latencies of the a-waves (photoreceptor responses) and b-waves (bipolar cell and Muller
cell responses) were stored in a Compact Flash storage card and fit to a computational
model to determine transduction parameters for photoreceptor responses.

Freezing and embedding:
SD normal and P23H-1 transgenic rats were euthanized at postnatal day 30. The
eyes were enucleated and frozen rapidly on dry-ice for low temperature cryoimaging. For
fluorescence imaging, the tissue was embedded in a customized black mounting medium
(that is not fluorescent in the excitation wavelengths) and placed on a chilled aluminum
plate to keep the tissue in place for freezing and slicing. The embedding process starts
with freezing the base medium, embedding the tissue and fixing its position by adding
more black medium around the tissue. After embedding, the tissue was stored in an
ultralow freezer for subsequent imaging. The plate was then installed in the cryoimager
where the surface of the black medium is parallel to a microtome. Figure 32 shows a
frozen eye sample and an eye sample embedded in the customized black mounting
medium.

Imaging calibration:
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A calibration method was designed to compensate for day-to-day variation of
light intensity and non-uniformity of the illumination pattern. At the beginning of each
experiment and before slicing the tissue, a uniform fluorescent flat plate was placed in the
same position as tissue and imaged in NADH and FAD channels to acquire the
illumination pattern. Since the fluorescence of the standard is in both the NADH and
FAD channels, it also accounts for day-to-day light intensity and uniformity changes in
all channels. All the images in each channel were then normalized by dividing each
image to the flat plate image, captured in the same channel.

Cryoimager:
The cryoimager, which is shown in Figure 33 is an automated image acquisition
and analysis system consisting of software and hardware designed to acquire
fluorescence images of tissue sections. A motor-driven microtome sequentially sections
frozen tissue at the desired slice thickness whereas filtered light from a mercury arc lamp
excites up to five fluorophores in the exposed surface of the tissue block. The excitation
light source is a 200W white light filtered at the excitation and emission wavelengths of
NADH and FAD. At each slice, a CCD camera records fluorescence image of the tissue
block in pixel dimensions of 10 µm × 10 µm to be later analyzed for fluorophore
distribution. The microtome is housed in a freezer unit that maintains the sample at -20°C
during sample slicing and image acquisition. The resolution in the z direction of
microtome slices can be as small as 5 um. For this study, we used a resolution of 10 um
in the z direction, which resulted in ~ 500 z-slices per eye. (Bernard, Ewen et al. 2000;
Sepehr, Staniszewski et al. 2012)
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Image processing:
NADH and FAD autofluorescence images (containing 500 slices per eye) from
each group of eyes were processed using MATLAB. Composite images were created
using all the image slices for each eye, for both NADH and FAD signals. The ratio of
NADH and FAD, was calculated voxel by voxel, using MATLAB, according to equation
(1).
NADH Redox Ratio = RR = NADH / FAD

(1)

The 2D representation of each eye was then calculated using the maximum
intensities along the z axis of the NADH redox 3-D volume (maximum projection). In the
maximum projection method, first a full 3D volume of images was obtained, including
RR, and then the maximum projection on the volumetric data was performed and the
histograms were plotted for this maximum projection. The maximum projection is used
since the entirety of the anatomy has a significant contribution in this representation. A
histogram of the max projection of RR values in each group was created, and the mean
(or first moment) of this histogram was calculated according to Eq. (2).

1
Mean 
Nx  Ny

Nx Ny

 eye _ Maxpro(i, j)

(2)

i 1 j 1

Where Nx and Ny are the number of pixels in the x and y directions and the pixel size in x
and y is 10μm and 10μm. The previously mentioned histograms were calculated for
quantitative comparison between normal and diseased groups.
Statistical evaluation of data
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Data are presented as mean ± SEM. A mixed model 2 x 6 ANOVA with animal group
(P23H vs. SD) as the between-subjects factor and flash intensities of the scotopic
intensity series as the within-subjects factor was used to analyze ERG data. A
Greenhouse-Geisser correction (a-wave =.500; b-wave =.460) was performed as the
assumption of sphericity was violated for the a-wave (X2 = 31.140, p = .006) and b-wave
(X2 = 28.381, p = .016) data. An unpaired Student’s t-test was used for comparing mean
values of NADH redox ratio and a-wave and b-wave implicit times at 100mcd.s/m2.
Statistical analysis was performed using SPSS 19.0 (SPSS Inc, Chicago, IL) and
GraphPad Prism 4.0 (GraphPad, La Jolla, CA USA). The level of significance for all
statistical tests was set at 0.05.

Results
In the present study, we used the cryo-fluorescence redox imaging method to
probe the retinal mitochondrial redox state. The method was performed on P23H
transgenic eyes and SD normal eyes at postnatal day 30, to determine the effect of disease
on the NADH RR. This method detects changes in the oxidation state of the
mitochondrial respiratory chain. Thus, NADH RR can be used as a quantitative marker to
evaluate the OS in diseased and normal eye tissue.
3-D rendering of NADH redox images is generated from representative eye
sample (not included in this dissertation as the figure is in the process of submission for
the cover page of Journal of Biomedical Optics). The optic nerve of the eye can be seen
in this figure. The 3-D rendering shows the capability of the cryoimager to perform 3-D
cryofluorescence imaging on intact tissue.
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Figure 43 displays, maximum projection images of NADH, FAD, and NADH RR
for a representative eye in transgenic and SD normal groups. The images show a
significant decrease in the mean NADH RR of eyes from diseased versus SD normal eye.
The eyes in the SD normal group (first column in Figure 43) show a lower concentration
of FAD and a higher concentration of NADH compared to diseased group (second
column in Figure 44). Thus, the NADH RR is higher (more reduced) in eyes from SD
normal rat eye compared to the eyes from transgenic rats (more oxidized). Sections from
the P23H transgenic rats consistently demonstrated increased OS as shown in Figure 4 by
a decreased NADH RR.
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Figure 43 Representative max projected NADH, FAD and RR images for eyes from
normal and disease groups.

Figure 44 shows the NADH redox histograms of a representative eye in each of
the SD normal and diseased groups. In the diseased group the NADH RR indicates a
more oxidized biochemical state with a mean value of 0.821 compared with a higher
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mean value of 1.079 in SD normal eyes. There was a blue shift in histograms from P23H
transgenic eye versus the normal eye and the NADH redox histogram shows a 24%
oxidation in the respiratory chain in this group.

Figure 44 A representative histogram for eyes from normal and diseased groups

comparing Redox Ratio intensity between P23H transgenic retina vs. SD Normal
retina. Oxidative stress causes more oxidation in the NADH redox histogram
Figure 45 compares the mean values of the histograms of max projected images
from SD normal and diseased groups. The results show a significant difference (p <.001)
between P23H transgenic eyes versus the SD normal eyes (n=4 in each group).
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Figure 45 Bar graph plot comparing the mean values of the histograms of max
projected images from SD and P23H transgenic rat eyes. The results show a
significant difference between normal and diseased eyes (***p<.001). Error bars:
SEM; p values were obtained from Unpaired Student’s t- test.

Figure 46 summarizes the differences in photoreceptor function between Sprague
Dawley rats and P23H-1 transgenic rats. When the function of the photoreceptors (awave amplitude; Figure 46A) and inner retina (b-wave amplitude; Figure 46B) was
assessed by dark-adapted, full-field flash ERG (scotopic intensity series protocol) at P30,
there was a linear increase in the ERG amplitude in both non-dystrophic SD and
dystrophic P23H rats (F(1,14) = 186.970, p <0 .001). The main effect of mean ERG
amplitudes between non-dystrophic SD and dystrophic P23H rats for a-wave (F(1, 14) =
161.0, p <.001; Fig. 46A) and b-wave ( F(1, 10) = 35.4, p <.001; Fig. 46B) of the scotopic
intensity series protocol were significantly different. In agreement with the previous
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studies, P23H transgene caused a significant decrease in both a-wave and b-wave
amplitudes compared to the normal SD controls.

Figure 46 A) The mean a-wave amplitude assessed by the scotopic intensity series
protocol comparing P23H transgenic (■; n=8) and SD normal control (▲; n=8)
groups B) The mean b-wave amplitude comparing P23H transgenic (■; n=6) and
SD normal control (▲; n=6) groups. P23H transgene caused a significant
decrease in both a-wave (F(1, 14) = 161.0, p < .001; Fig. 46A) and b-wave ( F(1, 10)
= 35.4, p < .001; Fig. 46B) amplitudes at all flash intensities compared to the
normal SD controls. Error bars: SEM.
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Figure 47 compares the a-wave and b-wave peak latencies referred to as implicit
times. P23H transgene caused a significant (P<.01) delay in both a- and b- wave implicit
times in P23H retina when compared to SD normal controls. The delay and deviations of
the implicit time topography in retinitis pigmentosa when compared to normal subjects is
a characteristic diagnostic tool.

Figure 47 shows the a-wave implicit time as well as b- wave implicit time
assessed at 100mcd.s/m2. The implicit times reflecting peak latencies of
a- and b- waves were significantly (**p<.01) different between P23H
transgenic and normal SD retina. Error bars: SEM; p values were obtained
from Unpaired Student’s t- test.
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Discussion and conclusion
Rod

specific

mutations,

which

are

genetically

heterogeneous

trigger

photoreceptor cell death by apoptosis in various forms of RP and other inherited retinal
degenerations. Recent studies suggest that death of cone photoreceptors subsequent to rod
cell death are due to increased oxidative and nitrosative stress (Shen, Yang et al. 2005;
Usui, Komeima et al. 2009). The retina is particularly vulnerable to oxidative damage
since it is one of the highest oxygen consuming tissues of the body and about 90% of
tissue oxygen is metabolized within the mitochondria (Yu and Cringle 2001). As reported
in induced and inherited retinal degeneration models, photoreceptors die due to OS,
mitochondrial dysfunction and apoptosis (Dykens, Carroll et al. 2004). There are several
potential sources of ROS generation in inherited retinal degenerative diseases that may be
either caused or exacerbated by reduced oxygen consumption due to the loss or inactivity
of mutant rod photoreceptors. Markers of oxidative damage to proteins, lipids and DNA
have been detected in cone photoreceptors in the transgenic pig model of RP that
suggesting that as the rod photoreceptors degenerate, there is a reduction in oxygen
consumption in the outer retina resulting in hyperoxia in the photoreceptor layer with
subsequent increase in oxidative stress, resulting in cone loss (Cassarino, Swerdlow et al.
1998; Yu and Cringle 2001). Understanding the biochemical mechanisms involved in
cone photoreceptor degeneration is important since cone loss is the major reason for
visual loss in RP. The above hypothesis is supported by the fact that photoreceptor
depletion-induced hyperoxia is a factor that makes the degeneration process progressive
as seen in models of retinal degeneration. Increasing evidence supports the therapeutic
efficacy

of

mitochondrial

targeted

agents

including

MITO

4565,

TUDCA
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(tauroursodeoxycholic acid), minocycline and cyclosporine A in various models of retinal
and neurodegenerative disorders (Cassarino, Swerdlow et al. 1998; Dykens, Carroll et al.
2004; Phillips, Walker et al. 2008; Yang, Kim et al. 2009).
The metabolic state of a cell is reflected in mitochondrial oxidative function.
Mitochondrial oxidative metabolism is an important biomarker for the diagnosis and
treatment of many disease pathologies, including cancer, autoimmune disorders and
neurodegenerative diseases (Green and Evan 2002; Todaro, Zeuner et al. 2004). In this
study, we used a 3-D cryofluorescence redox imaging technique to quantify and compare
the mitochondrial redox state in normal and diseased retinae.
In the presence of hyperoxia, as seen in RP and other inherited retinal
degenerations, the coenzymes NADH and FADH2 accumulate in their oxidized forms
(NAD and FAD). We therefore anticipated higher concentrations of FAD and lower
concentrations of NADH in the P23H retina compared to SD normal retina. It can be seen
from the maximum projection images in Figure 4 that the FAD concentration is higher
(brighter images) and NADH concentration is lower (darker images). This results in the
NADH RR showing a significant decrease in the degenerating eye as compared to the SD
normal. The difference in the mean values of the two histograms in Figure 5 suggests that
OS caused by the disease in transgenic eyes is the reason for a shift in metabolic levels of
the eye tissue and causes the mitochondrial respiratory chain to be more oxidized. The
24% oxidation in the NADH RR that we observed in the retina of P23H transgenic rat
model suggests that substantial mitochondrial OS is a significant early cellular event in
RP. The significant difference in the mean NADH RR of eyes from transgenic rats
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compared with their appropriate controls (SD normal eyes) suggests that the NADH RR
can be used as a marker of retinal OS.
We observed an increase in signal intensity in the eye samples from the vitreous
in both NADH and FAD channels that needs to be further investigated and explained.
Changes in the biochemical composition of vitreous following pathological changes in
the retina during the degeneration process may be one of the reasons for those isolated
signals. Collagen, elastin, flavins and lipo-pigments (ceroid and lipofuscin) are some of
the endogenous tissue fluorophores that has excitation emission spectral overlap with
NADH (Wagnieres, Star et al. 1998). It has also been shown that upon binding to a
protein, the quantum yield of NADH increases by four fold (Joseph 2006). Proteomic
changes in the vitreous humor have been reported in micro vascular pathologies including
proliferative diabetic retinopathy (Kim, Kim et al. 2007).
Our results demonstrate the quantitative capability of an optical cryoimaging
technique to measure the tissue mitochondrial redox state in the normal and diseased rat
retina. Our method is a direct analysis of the cellular metabolic state within the
mitochondrial compartment of the retina of P23H transgenic rat model of Retinitis
Pigmentosa, which has not previously been reported. Furthermore, the studies presented
here set the stage for future studies, using ex vivo and in vivo fluorescence imaging of
mitochondrial redox states of retina to characterize disease progression in various retinal
dystrophies and to evaluate mitochondria targeted drug regimens that diminish OS.
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CHAPTER 6
COMPARISON OF 670 nm vs. 830nm PHOTOBIOMODUALTION
USING THREE TREATMENT PARADIGMS
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To compare the efficacy of 670nm and 830nm NIR photobiomodulation in protecting
photoreceptors against damage induced by the P23H transgene, three NIR-LED treatment
paradigms were investigated. The first treatment protocol determined whether NIR PBM
can rescue photoreceptor function during the critical period (p10-p25) of photoreceptor
development. The second treatment protocol determined whether NIR PBM can mitigate
the degenerative process from the onset of the critical period of photoreceptor cell death
to young adulthood (p10-p 40) and the third treatment protocol determined the ability of
NIR PBM to rescue remaining photoreceptors (p20-p40) and preserve retinal function in
young rats in which the majority of rods have degenerated.
Figure 48 compares the a-wave amplitude (panel A), b-wave amplitude (panel B), the
average implicit time for both a- and b-wave (panel C) at the initial flash intensity of the
scotopic intensity series response and the mean total retinal thickness (panel D) for both
830nm (left panel) and 670nm (right panel) NIR PBM during the critical period of
photoreceptor development. The main effect of mean ERG amplitudes for the a-wave
response which reflect photoreceptor activity and b-wave response which originates
from post-synaptic neurons was significantly different between P23H and the treated
group in 830nm study [a-wave: (F(1,14) = 16.32 , p < .001); b-wave: (F(1,22) = 23.57, p <
.001)] when compared to that of the 670nm study [a-wave: (F(1,22) = .396 , p =.536); bwave: (F(1,11) = 2.11, p =.173)]. The implicit time at 100mcd.s/m2 was significant for both
a-wave (p<.01) and b-wave (p<.05) in the 830nm study but was not significant with the
670nm study. Total retinal thickness decreases as rod photoreceptors degenerate and
disrupt the cellular architecture of the retina and our results demonstrate that 830nm
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study significantly attenuated (p<.01) the thinning of retina in SDOCT linear scans. As
similar trend was observed with 670nm study but was not statistically significant.
Figure 49 compares the functional and structural changes in P23H transgenic
retina following NIR PBM by 830nm (left panel) and 670nm (right panel) photons during
the onset of the critical period of photoreceptor cell death to young adulthood (p10-p 40).
The main effect of mean ERG amplitudes for a-wave (panel A) response and b-wave
response (panel B) was significantly different between P23H and the treated group in
830nm study [a-wave: (F(1,14) = 16.63 , p < .01); b-wave: (F(1,14) = 14.6, p < .01)] when
compared to that of the 670nm study [a-wave: (F(1,10) = .279 , p =.609); b-wave: (F(1,11) =
2.01, p =.172)]. The implicit time for a- and b-waves in both 830nm study and 670nm
study was not statistically significant (panel C). As 670nm PBM did not preserve the
retinal structure in the p10-p25 study, SD-OCT imaging was not conducted in p10-p40
and the p20-p40 study. 830nm PBM continued to preserve the structural integrity (panel
D) of the retina in the p10-p40 study, but was not significantly different from the nontreated P23H group.
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Figure 48 compares the functional and structural changes in P23H transgenic
retina following NIR PBM by 830 and 670 nm photons during the critical period
of photoreceptor degeneration (p10-p25). Panel A compares the a-wave amplitude
and panel B compares the b-wave amplitude between P23H (■) and 830 nm
treated group (▲, left), P23H (■) and 670 nm treated group (▲, right)
respectively. The main effect for a-wave and b-wave between the groups are
significantly different [a-wave: (F(1,14) = 16.32 , p < .001); b-wave: (F(1,22) = 23.57,
p < .001)] in 830 nm treated group when compared to that of the 670 nm treated
group [a-wave: (F(1,22) = .396 , p =.536); b-wave: (F(1,11) = 2.11, p =.173)]. Panel C
compares the implicit time for a-wave and b-wave at 100mcd.s/m2. 830 nm
treatment caused a significant difference in a-wave (p<.01) and b-wave (p<.05)
when compared to the 670 nm group even though a trend was observed in the
later. Panel D shows total retinal thickness measured by SD-OCT demonstrating
retinal structural integrity which was significantly different (p<.01) in 830 nm
treated group at both 0 degree and 90 degree linear scans when compared to P23H
group but 670 nm treatment demonstrated a trend without a statistically
significant result. Error bars: SEM.
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Figure 49 compares the functional and structural changes in P23H transgenic
retina following NIR PBM by 830 and 670 nm photons during the onset of the
critical period of photoreceptor cell death to young adulthood (p10-p 40). Panel A
compares the a-wave amplitude and panel B compares the b-wave amplitude
between P23H (■) and 830 nm treated group (▲, left), P23H (■) and 670 nm
treated group (▲, right) respectively. The main effect for a-wave and b-wave
between the groups are significantly different [a-wave: (F(1,14) = 16.63 , p < .01);
b-wave: (F(1,14) = 14.6, p < .01)] in 830 nm treated group when compared to that
of the 670 nm treated [a-wave: (F(1,10) = .279 , p =.609); b-wave: (F(1,11) = 2.01, p
=.172)]. Panel C compares the implicit time for a-wave and b-wave at
100mcd.s/m2 and there was no statistically significant difference between P23H
and both treatment groups. Panel D shows total retinal thickness measured by SDOCT linear scans representing retinal structural integrity which was not
statistically significant between P23H and 830 nm treated group. Error bars:
SEM.
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Figure 50 compares the functional and structural changes in P23H transgenic
retina following NIR PBM by 830 and 670 nm photons during the later stage
(p20-p 40) to rescue remaining photoreceptors. Panel A compares the a-wave
amplitude and panel B compares the b-wave amplitude between P23H (■) and
830 nm treated group (▲, left), P23H (■) and 670 nm treated group (▲, right)
respectively. The main effect for a-wave and b-wave between the groups are
significantly study [a-wave: (F(1,22) = 4.60 , p < .05); b-wave: (F(1,20) = 5.85, p <
.05)] in 830 nm treated group when compared to that of the 670 nm treated [awave: (F(1,10) = .00 , p =.99); b-wave: (F(1,10) = 0.28, p =.608)]. Panel C compares
the implicit time for a-wave and b-wave at 100mcd.s/m2 and there was no
statistically significant difference between P23H and both treatment groups. Panel
D shows total retinal thickness measured by SD-OCT linear scans representing
retinal structural integrity. 90 degree linear scans were statistically significant
between P23H and 830 nm treated group (p < .05) but in contrast 0 degree scans
were not statistically significant (p =.05). Error bars: SEM.
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Figure 50 compares the functional and structural changes in P23H transgenic retina
following NIR PBM by 830 (left panel) and 670 nm (right panel) photons during the
later stage (p20-p 40) to rescue remaining photoreceptors. The main effect of mean ERG
amplitudes for a-wave response

(panel A) and b-wave response (panel B)

was

significantly different between P23H and the treated group in the 830nm PBM study [awave: (F(1,22) = 4.60 , p < .05); b-wave: (F(1,20) = 5.85, p < .05)] as seen in previous two
treatment paradigms when compared to that of the 670nm study [a-wave: (F(1,10) = .00 , p
=.99); b-wave: (F(1,10) = 0.28, p =.608)]. There was no difference in a-wave or b-wave
implicit times between the 670 nm and the 830 nm treatments. (panel C). Interestingly we
observed better preservation of retinal structure with 830nm PBM in the 90 degree linear
scans (p<.05), even though treatment started in young adult rats which has the majority of
rods degenerated (paned D). This observation provides new insights into the ability of
PBM to preserve the secondary retinal structures and enhance self-renewal and repair of
the retinal cells that generally undergo degeneration as rod photoreceptors die.
In summary the results demonstrated in this study shows that 830nm PBM generates
more robust cellular and physiological response in P23H transgenic rats when compared
to the 670nm PBM in three treatment paradigms.
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CHAPTER 7
PHOTOBIOMODUALATION
ATTENUATES
RETINAL
DEGENERATION IN THE P23H RAT MODEL OF RETINITIS
PIGMENTOSA

[In preparation for Investigative Ophthalmology & Visual Science]
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Introduction
Retinitis pigmentosa (RP) is a hereditary retinal degenerative disorder and the
most common cause of inherited blindness in the developed world, with an estimated 1.5
million patients worldwide and a prevalence of one in 5000 individuals worldwide1,2.
Clinically, RP is characterized by nyctalopia in the initial stages resulting from loss of
rod photoreceptors followed by patchy loss of peripheral vision in daylight which
progresses towards the center leading to tunnel vision resulting from secondary loss of
cone cells. Fundus images of patients with RP reveal attenuation of retinal vessels, waxy
palor in the optic disc and pigment deposits in the peripheral retina that resemble bony
spicules3. Although the majority of RP cases are monogenic, the disease is characterized
by its genetic heterogeneity and more than 40 genes have been associated with RP. RP
can be inherited in an autosomal dominant, recessive, X-linked or mitochondrial mode4.
RP is associated with gene defects in proteins involved in the visual transduction cascade,
RPE function, photoreceptor structure and RNA splicing4. The first gene abnormality
reported in RP was a single-base substitution in codon 23 of rhodopsin gene (RHO). This
mutation [proline 23 histidine] (P23H) accounts for 12% of autosomal dominant RP in
US5.
Rod and cone photoreceptors are the most metabolically active cells in the CNS
with a high rate of oxygen consumption. Cones are more metabolically active than rods;
however rods greatly outnumber cones in the retina. As rod photoreceptors degenerate in
clinical and experimental RP, there is a decrease in oxygen consumption in the retina that
results in increased oxygen tension6. Choroidal vessels are poorly autoregulated and
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cannot compensate for this increased oxygen tension, resulting in outer retinal hyperoxia
and an altered intracellular redox equilibrium leading to increased oxidative stress7.
Considerable evidence supports a key role for mitochondrial dysfunction and
oxidative damage in the pathogenesis of photoreceptor cell death in RP and other retinal
degenerative disorders8,9. Despite the degree of genetic heterogeneity, human retinal
dystrophies have been associated with profound loss of retinal antioxidant systems and
cytoprotective factors thus compromising the ability of retinal neurons and glia to protect
against oxidative damage leading to apoptotic cell death10,11. Moreover, mitochondrial
dysfunction leading to increased oxidative stress and abnormal regulation of apoptosis
are characteristic findings of many inner and outer retinal disorders including Leber’s
hereditary optic neuropathy (LHON), glaucoma, age-related macular degeneration
(AMD) and diabetic retinopathy12,13,14.
Photobiomodulation (PBM) is defined as a process by which cellular signaling
pathways are activated when photons interact with cellular photoacceptor molecules
leading to physiological changes in the cell. Treatment of tissue with monochromatic
photons in the far-red to near-infrared (NIR) region of the spectrum (630-1000 nm) has
been shown to attenuate the harmful effects of neuro- and developmental toxins and
improve recovery from ischemic reperfusion injury in the heart15-18. PBM has also been
shown to attenuate degeneration in the injured retina and optic nerve, ameliorate the
retinotoxic effects of methanol-derived formic acid in rodents and improve recovery in
experimental and clinical stroke19-23.
Recent studies from our laboratory have demonstrated that NIR photons
decreased the concentrations of cytotoxic and pro-apoptotic factors and reduced cell
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death and inflammation in rodent models of light-induced retinal degeneration and
multiple sclerosis24,25.

Fitzgerald and colleagues demonstrated that NIR photons

delivered transcranially to the injury site in an in vivo model of partial optic nerve
transection resulted in a decrease in secondary oxidative stress in astrocytes, an increase
in NG-2 immunopositive oligodendrocyte precursor cells and restored visual function22.
Increasing evidence indicates that cytochrome c oxidase, the terminal electron
acceptor of the electron transport chain, is a key photoacceptor molecule mediating the
therapeutic actions of photobiomodulation26. The interaction of NIR photons with
cytochrome c oxidase increases the mitochondrial membrane potential (ΔΨ) and proton
gradient in the intermembrane space of the mitochondria27, modifies NADH linked
dehydrogenase reactions28 and alters the rate of ADP/ATP exchange29 resulting in the
activation of intracellular signaling cascades which culminate in improved mitochondrial
function, increased synthesis of cytoprotective factors and cell survival19. Microarray
studies have identified genes and noncoding RNAs involved in the neuroprotective
actions of NIR-PBM in light induced retinal degeneration model. These studies
demonstrated significant up-regulation of gene expression in pathways involved in
mitochondrial energy production and antioxidant cellular protection and down-regulation
of gene expression in pathways involved in apoptotic cell death30.
Mitochondrial dysfunction is a hallmark finding in retinal and neurodegenerative
disorders and PBM has been shown to improve cellular mitochondrial energy metabolism
in cultured cells and in animal models of disease. The purpose of this investigation was
to test the hypothesis that 830nm photobiomodulation would slow disease progression
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and improve retinal metabolic state in an animal model of retinal dystrophy, the P23H
transgenic rat.

Materials and Methods
Animals
All animal experiments were approved by the Institutional Animal Care and Use
Committee (IACUC) and were conducted in accordance with the ARVO (The
Association for Research in Vision and Ophthalmology) statement for the use of animals
in ophthalmic and vision research and with the National Institutes of Health regulations.
Heterozygous P23H-1 transgenic rats, the offspring P23H-1 homozygotes (Retinal
Degeneration Rat Model Resource, UCSF) and Sprague-Dawley (SD) albino rats (Harlan
Sprague Dawley, Madison, WI) were used as the model of RP. All animals were housed
and bred in an AAALAC approved animal at the University of Wisconsin-Milwaukee.
Rats were fed ad libitum and maintained in a temperature and humidity-controlled
environment under dim cyclic light, 12-hour light/12-hour dark cycle, with an average
illuminance of 5 to 10 lux inside the cage.
NIR Treatment Protocol
P23H-1 transgenic rat pups were treated with 830 nm LED arrays engineered to
eliminate heat (GaAlAs LED arrays, QBMI Photomedicine, Barneveld WI). Rat pups
were hand-held by the investigator or placed in a plexiglass restraint device and the 830
nm LED array was positioned directly over the animal’s head at a distance of 2 cm
exposing both eyes. Treatment protocol consisted of irradiation at 830 nm for 180
seconds at power intensity of 25mW/cm2 and an energy density of 4.5 joules/cm2 at the
surface of the cornea. Sham-treated P23H-1 transgenic pups were handled in the same
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way, except that they were not exposed to the LED array. Animals in the NIR-PBM
treated group were treated once a day for 5 days per week from p10 to p25.
Electroretinography
Photoreceptor

function

was

assessed

by

full-field

flash-evoked

electroretinography (ERG). At p30, animals were dark-adapted overnight and prepared
under red dim light. Animals were anesthetized with a ketamine and xylazine cocktail
(100 mg/kg and 5 mg/kg respectively, ip) and placed on a heating pad at 37°C during
recordings.

Pupils were dilated with 0.1% atropine and mild topical anesthesia

(proparacaine 0.5%).

Full-field ERGs were obtained in a Ganzfeld dome (76 mm

diameter Flash Dome with 55 mm aperture) using nylon coated gold thread electrode
placed on the corneal surface, overlaid with 1% methylcellulose and a contact lens. A sub
dermal needle reference electrode and a ground needle electrode were placed in the cheek
and tail respectively. A high-intensity flash unit (HMsERG instrument, Retvet Corp, MO)
was used to provide flash intensities (ranging from 10 mcd.s/m2 to 25000 cd.s/m2) for
scotopic intensity series response measurements. The ISCEV protocol was also employed
to examine rod-mediated and rod and cone-mediated responses. Signals were amplified,
digitized and averaged using ERG view 2.5 software (RetVet Corp. Inc., Columbia, MO).
A custom designed Faraday cage was employed to block 60 cycle electrical noise. The
amplitudes and latencies of the a-waves (photoreceptor responses) and b-waves (bipolar
cell and Muller cell responses) were fit to a computational model to determine
transduction parameters for photoreceptor responses.
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Spectral Domain Optical Coherence Tomography (SD-OCT) imaging
High-resolution scans were performed at p30 to assess retinal morphology using
SD-OCT (Bioptigen Inc, Research Triangle Park, NC). Animals were anesthetized with a
ketamine and xylazine cocktail (i.p., 50:5 mg/kg body weight) and were placed on a
custom made six-axis animal alignment system. Both eyes were imaged in a single
session after dilation of pupil (1% Atropine sulphate) and hydration of cornea (Systane
ultra, polyethylene glycol 400, 0. 4%). The fundus imaging camera in the optical head of
the OCT provided initial alignment for the light source during the real time aiming. Final
positioning was guided by monitoring and calibrating the real-time OCT image of the
retina formed. The optic nerve head (ONH) was used as a landmark (Figure 51a and
Figure 51b) and linear (1000 A-scans/B-scan, 80 B-scans) and volume scans (750 Ascans/B-scan, 250 B-scans/volume) per eye were captured and saved using the
Bioptigen's InVivoVueTM software. For the linear scans, the B-scans were registered and
averaged as previously described31 using ImageJ

32

(National Institutes of Health,

Bethesda, MD) and segmentation of retinal layers for total thickness were determined
using an algorithm generated in MatLab (The MathWorks, Inc. , Natick, MA). The
difference in reflectivity of retinal layers was used in generating longitudinal reflectivity
profile33 (LRP, Figure 51c) and based on the LRP at fixed locations on either side for the
ONH, outer nuclear layer thickness (ONL) was determined as demonstrated in Figure
51d.
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Figure 51 a and 51 b shows the ONH landmark used for SDOCT imaging. Figure 51c
shows the difference in the reflectivity of retinal layers from which Longitudinal
Reflectivity Profile (LRP) is generated. Low reflecting layers in the linear scan
correspond to nuclear layers and high reflecting layers correspond to synaptic layers in
the retina31, 53. NFL, nerve fibre layer; GCL, ganglion cell layer; OPL, outer plexiform
layer; ONL, outer nuclear layer; IS/OS, inner segment/outer segment junction; BM,
Bruch's membrane. Figure 51 d represents the LRP lines 50Px apart on either side of the
ONH (100Px width) used for characterizing the ONL thickness.
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Tissue Collection and Toluidine Blue Staining
Animals were euthanized at p30 by CO2 inhalation and the eyes were rapidly
enuculeated for histological evaluation. The eyes were marked at superior position (in
the corneal limbus) using a surgical cautery and immersion-fixed in 4%
paraformaldehyde in 0.1 M phosphate-buffered saline (PBS) at pH 7.4 for 2 h. Sections
(10 µm) were stained with toluidine blue and examined using an Olympus Axioskop
microscope to evaluate structural changes in the retina as described previously24.
Measurement of ONL thickness
The number of surviving photoreceptors was quantified by counting the rows of
photoreceptor nuclei in the ONL in digital images of toluidine blue stained resin sections
at three locations (100 µm, 200 µm and 300 µm from the optic nerve head) on the
superior pole and inferior pole of the optic nerve as previously described34.
Freezing and embedding tissue for Optical Cryo Imaging
Retinal metabolic state was assessed using a novel optical redox-sensitive
cryoimaging technique. Animals were euthanized at p30, and their eyes were harvested
and frozen rapidly for low temperature cryoimaging. The eyes were embedded in a
customized black mounting medium (Figure 32) to remove the background fluorescence
and scanned by the cryoimager. The cryoimager (Figure 33) is an automated image
acquisition and analysis system consisting of software and hardware designed to acquire
fluorescence images of tissue sections. The excitation light source is a 200W mercury arc
lamp filtered at the excitation wavelength of NADH and FAD, 336 nm and 470 nm,
respectively. The emission wavelengths are 450 nm and 520 nm for NADH and FAD and
respectively. At each slice, a CCD camera records a fluorescence image of the tissue
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block. The resolution in the z direction of microtome slices can be as small as 5 µm. For
this study, we used a resolution of 10 m in the z direction, which resulted in ~ 400 zslices per eye.
FAD and NADH autofluorescence images from each group of eyes were
processed using Matlab. The composite images were created using all the image slices for
each eye, for both NADH and FAD signals. The ratio of NADH and FAD, known as the
NADH redox ratio35, was calculated voxel by voxel, using Matlab, according to equation
(1).
Redox Ratio = RR = NADH / FAD

(1)

The 2D representation of each eye was then calculated using the maximum
intensities in the z axis of the NADH redox 3D volume (not included in this dissertation
as the figure is in the process of submission for the cover page of Journal of Biomedical
Optics). In the maximum projection method, first a full 3D volume of images was
obtained, including RR, and then the maximum projection on the volumetric data was
performed and the histograms were plotted for this maximum projection. The maximum
projection is used since the entirety of the anatomy has a significant contribution in this
representation. A histogram of the max projection of RR values in each group was
created, and the mean (or first moment) of this histogram was calculated according to Eq.
(2).

Mean 

1
Nx  Ny

Nx Ny

 eye _ Maxpro(i, j)
i 1 j 1

(2)
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Where Nx and Ny are the number of pixels in the x and y directions and the pixel size in
x and y is 10μm and 10μm. The previously mentioned histograms were calculated for
quantitative comparison between P23H-sham and P23H-NIR-treated groups.

Data Analysis
Data are presented as mean ± SEM. A mixed model ANOVA (GreenhouseGeisser correction was performed whenever the assumption of sphericity was violated),
MANOVA, 1-way ANOVA (Kruskal-Wallis test) and Student's t-test performed, as
appropriate. Statistical analysis was performed using SPSS 19.0 (SPSS Inc, Chicago, IL)
and GraphPad Prism 4.0 (GraphPad, La Jolla, CA USA). The level of significance for all
statistical tests was set at .05.

Results
830 nm photobiomodulation preserved retinal function in the P23H rat
Figure 52 summarizes the changes in photoreceptor function in P23H transgenic
retina following photobiomodulation by 830 nm NIR photons during the critical period
(p10-p25) of photoreceptor loss.

When the function of the photoreceptors (a-wave

amplitude; Figure 52 a) and inner retina (b-wave amplitude; Figure 52 b) was assessed by
dark-adapted, full-field flash ERG (scotopic intensity series protocol) at p30, there was a
linear increase in the ERG amplitude in both NIR treated P23H and non-treated P23H
groups. In agreement with previous studies, the P23H transgene caused a profound
decrease in both a-wave and b-wave amplitudes compared to the normal SD controls
(data not shown) that was rescued by treatment with 830nm NIR photons.
Figure 52 a summarizes the comparison of mean a-wave ERG amplitude over a
range of flash intensities (from 10 mcd.s/m2 to 25000 cd.s/m2) between NIR-treated and
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sham treated P23H-1 transgenic rats. The a-wave amplitude curve in the NIR-treated
animals was significantly greater (F(1, 14) = 16.32, p < .001; Fig. 52a) than that measure in
the sham-treated animals indicative of protection of photoreceptor function by 830 nm
PBM. The effects of NIR treatment on the functional response post synaptic to
photoreceptors was assessed by measuring the b-wave amplitude over the same range of
flash intensities in NIR-treated and sham-treated rats. Figure 52 b shows the mean bwave amplitude in each treatment group. At each intensity the amplitude of the b-wave
was 50% greater in the NIR-treated animals compared to the sham-treated animals and
was significantly different (F(1, 22) = 23.57, p < .001; Fig. 52b).
Figure 52 c shows the average a-wave amplitude reflecting the rod-only response
in the ISCEV protocol. The rod-only response was significantly greater in the NIR treated
retina compared to the sham-treated retina (14.8 ± 2.2 µV vs. 8.8 ± 0.7; p < .05 µV, n=4).
Figure 52 d shows the average a-wave amplitude reflecting the standard rod and cone
response in the ISCEV protocol. The a-wave amplitude of the rod and cone-mediated
response was also significantly greater in the NIR-treated compared to the sham-treated
animals (69.2 ± 3.2 µV vs. 59.3 ± 0.8 µV; p < .05, n=3).
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Figure 52a shows the mean a-wave amplitude and figure 52b shows the mean bwave amplitude assessed by the scotopic intensity series protocol comparing
P23H transgenic retina (■) and 830 nm treated P23H retina (▲). 830 nm caused a
significant increase in both a-wave (F(1, 14) = 16.32, p < .001; n=8, Fig. 52a) and bwave amplitudes ( F(1, 22) = 23.57, p < .001; n=12, Fig. 52b) at all flash intensities
compared to the P23H group. Figure 52c shows the ISCEV protocol for Rod only
response (a wave; flash strength -10mcds/m2) which was significantly (p<.05)and
Figure 52d shows ISCEV protocol for Standard Rod and Cone response (a wave;
flash strength -3000 mcds/m2). Error bars: SEM.
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830 nm photobiomodulation preserved retinal structure in the P23H rat
Figure 53 a shows a comparison of the total retinal thickness of P23H transgenic
group with the in NIR-PBM treated group using SD-OCT at p30. In our studies the
preservation of total retinal thickness was evident in the in NIR-PBM treated group
compared to the non-treated group. The mean total retinal thickness was significantly
(p<.01) higher in NIR-PBM treated group (171.1 ± 2.0 µm, n=5) when compared to the
P23H group (169.2 ± 3.1µm, n=5). Figure 53 b compares the ONL thickness in µm at
identical locations on either side of the ONH. The ONL thickness of NIR-PBM treated
group was significantly greater (F(1, 8) = 12.23, p < .01; Fig. 53b) compared to the shamtreated group across the entire scan.
Figure 54 shows histologic labeling of plastic sections stained with toluidine blue,
which was used to detect surviving photoreceptors in the retina. Histomorphometry
demonstrated that the P23H transgene led to structural damage in the outer retina. The
ONL was disorganized and there was loss of photoreceptor nuclei and thinning of ONL
(Figure 55). The cumulative effect of photoreceptor cell death was assessed by the

measurement of the ONL thickness (Figure 55). The number of nuclei in the superior
segment of the ONL was significantly greater in the NIR-PBM treated group compared
the non-treated group and a similar trend was seen in the inferior segment of the eye.
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b
Figure 53a and b compares the total retinal thickness and ONL thickness
respectively from SD-OCT linear scans (1000 A-scans/B-scan, 80 B-scans). Total
retinal thickness was significantly (p < .05; Fig. 53a) higher in NIR-PBM treated
group when compared to the P23H group. The ONL thickness of NIR-PBM
treated group (▲) derived from Longitudinal Reflectivity Profile (LRP) was
significantly greater (F(1, 8) = 12.23, p < .01; Fig.53b) compared to the shamtreated group (●) across the entire scan.
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Figure 54 compares the representative images of retinal sections stained with
toluidine blue between sham-treated group and the NIR-PBM treated group. The
ONL in the NIR-PBM treated group is more organized and symmetrically packed
when compared to the sham-treated which was highly disrupted and disorganized.
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Figure 55 shows quantitative analyses of the ONL thickness sampled across the
retina from the superior to inferior edge (n = 4). ONL thickness in NIR-PBM
treated group is significantly greater compared to the P23H group. Error bars:
SEM.
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Efficacy of 830 nm photobiomodulation in P23H transgenic retina monitored by a
longitudinal study
Figure 56 and 57 summarize the changes in retinal structure over time following
NIR-PBM using SD-OCT. The retinoprotective effects of NIR PBM administered in
P23H transgenic rats during the critical period (p10-p25) diminishes as the animal
matures and statistically significant difference (p<.01) with the non-treated group was
found only at the time period, p25. At p25, the average total retinal thickness of P23HNIR group was 173.7 ± 2.0 µm compared to 159.6 ± 1.89 µm of the non-treated group.
However there was an increase trend in the total retinal thickness at p32 (161.6 ± 1.3 µm
vs. 155.1 ± 0.57 µm), p39 (156.3 ± 1.3 µm vs. 153.3 ± 1.8 µm) which diminishes at p80.

Figure 6a

Figure 56 compares the total retinal thickness between NIR-PBM treated group
and sham-treated group monitored in a longitudinal study using SD-OCT. The
retinoprotective effects of NIR PBM diminishes as the animal matures and
statistically significant difference (p<.01) with the non-treated group was found
only at the time period, p25. Error bars: SEM.
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Figure 57 compares representative linear scans at p18, p25, p32, p39 and p80
830 nm photobiomodulation preserved the mitochondrial redox state of the P23H
retina.
Figure 58 displays, from left to right, maximum projection images of NADH,
FAD, and NADH -RR (NADH/FAD) for a representative retina in normal (SD),
transgenic (P23H) and NIR treated (P23H-NIR) groups. The retina in the control group
(first column in Figure 58) showed a lower concentration of FAD and a higher
concentration of NADH compared to P23H transgenic retina (second column in Figure
58). Thus, the NADH RR is higher (more reduced state) in retina from normal SD eyes
compared to the eyes from P23H transgenic rats (more oxidized) suggesting the role of
increased oxidative stress and dysfunctional mitochondria in the P23H transgenic retina.
Sections from NIR-PBM treated group (third column in Figure 58) consistently
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demonstrated lower concentrations of FAD, higher concentration of NADH and higher
NADH RR compared to P23H transgenic retina demonstrating an altered mitochondrial
redox state following NIR-PBM, suggesting decrease in oxidative stress.
Figure 58 (lower panel) shows the NADH redox histograms of a representative
eye in each normal, P23H transgenic and NIR-PBM treated groups. In the P23H group
the NADH RR indicates a more oxidized mitochondrial redox state with a mean value of
0.80 ± 0.1 compared to a higher mean value of 1.2 ± 0.4 in normal control SD eye7.
NADH redox histogram for the representative NIR-PBM eye demonstrated a shift to the
right with a mean value of 1.02 ± 0.2.
Figure 59 compares the mean values of the NADH RR histograms of max
projected images from normal, P23H and NIR-PBM treated groups. The mean NADH
RR reveals a significant decrease (p<.001) in P23H transgenic eyes compared to normal
SD eyes suggesting an increased accumulation of ROS and mitochondrial dysfunction
leading to accumulation of oxidized forms (NAD and FAD) of the mitochondrial
coenzymes NADH and FADH as a result of the progressive retinal degeneration in the
P23H transgenic retina. 830 nm irradiation of the P23H retina significantly up regulated
the NADH RR (p<.01) by increasing the reduced NADH and decreasing FAD. These
results support the previous studies suggesting the ability of NIR-PBM to decrease
oxidative stress and improve mitochondrial function in progressive retinal and
neurodegenerative disorders22,19
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Figure 58 Upper panel shows a representative max projected NADH (upper
panel), FAD (middle panel) and RR images (lower panel) for normal (SD), P23H
transgenic and 830 nm treated transgenic eyes. Lower panel shows a
representative NADH redox histogram for eyes comparing normal (SD), P23H
transgenic and 830 nm treated transgenic eyes
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Figure 59 represents bar graph plot comparing the mean values of the histograms
of max projected images from SD, P23H transgenic and 830 nm treated P23H
transgenic rat eyes. The results show a significant decrease in the ratio between
normal and diseased eyes (**p<.01) which is reversed to normal by 830 nm
treatment (*p <.01). Error bars: SEM.
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Discussion
Even though photobiomodulation by NIR photons are extensively used by
researchers to demonstrate preservation and stimulation of cellular events in various
clinical and experimental animal models the use of photobiomodulation is still
controversial and debated because of the incomplete knowledge of the mechanism of
action and the differences in the treatment parameters used by various investigators like
range of wavelength, dose, and the nature of light source- Laser vs. non-coherent light ;
polarized vs. unpolarized; pulsed vs. continuous wave

36-39

. The altered kinetics of the

photoacceptor molecule (cytochrome c oxidase) after NIR photon interaction and how it
alters the mitochondrial redox state that triggers secondary signaling cascades which
culminate in improved mitochondrial function remains a ‘‘black box’’ and future
experiments should emphasize to resolve the above issues.
This report demonstrates that 830 nm PBM can ameliorate the disease progression
in the P23H rat model of RP. Recent studies have demonstrated the neuroprotective
action of photobiomodulation in several experimental models of progressive degenerative
disease including Parkinson’s disease40,41, Alzheimer's disease42, multiple sclerosis25,
light-induced retinal degeneration24,23 and age-related retinal inflammation40,

43,41

.

Clinical studies have confirmed the therapeutic potential of photobiomodulation at doses
ranging from 3 to 6 J/cm2 in radiation and chemotherapy-induced mucositis and
stroke20,44,45,46. A substantial body of evidence demonstrates that mitochondria are the
initial site of action of near-infrared photons leading to mitochondrial repair, increased
ATP production, attenuation of oxidative stress and induction of transcription
factors47,22,30,48,43. In vitro studies in our laboratory and by other investigators have
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shown that near-infrared radiation interacts with the key mitochondrial enzyme of the
electron transport chain, cytochrome oxidase, triggering signaling mechanisms that result
in improved mitochondrial energy metabolism, antioxidant production and cell survival18,
19, 49

. Moreover, NIR photon irradiation has been shown to increase electron transfer in

purified cytochrome oxidase50 and up regulate cytochrome oxidase activity in cultured
neuronal cells51. A similar pattern of thinning of ONL and severely distorted retina was
reported in a light-induced retinal degeneration model where NIR-PBM was shown to
preserve the retinal structure24.
Photobiomodulation promotes retinoprotection
Our findings demonstrate that 830 nm photobiomodulation during the critical
period (p10-p25) of photoreceptor degeneration in P23H transgenic rats protected against
the loss of photoreceptor function and preserved the structural integrity of retina. Both aand b-wave amplitudes were significantly greater in NIR treated animals indicative of a
protection of photorecptor function.

The functional protection demonstrated in this

manuscript agrees with that reported by Albarracin et al24 in a light-induced retinal
degeneration model. The in vivo imaging studies using SD-OCT corroborate the
histology data showing that ONL thickness was significnatly preserved in the NIRtreated animals. Morover better nuclear packing and more even arrangement in the ONL
was observed in the NIR treated retina compared to that of the sham-treated retina.
The longitudinal study measuring the total retinal thickness demonstrated that the
maximum protection is achevied if the photobiomodulation is applied during the critical
period. Photobiomodulation treatment parameters used in the study are based on those
used effectively by other researchers and the lens transmission spectral studies on albino
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rat lens demonstrate that the dose delivered on the surface of the lens and cornea will be
transmitted between 90 and 100%52,43. Importantly, there was no evidence of damage to
the normal, nonchallenged retina after NIR PBM.
To the best of our knowledge, there has been no other study that has examined
NADH/FAD RR expression in intact eye tissue before and after NIR PBM. This method
demonstrates a direct analysis of the cellular metabolic state within the mitochondrial
compartment of the retina. The two endogenous fluorophores in tissue that reflect cellular
metabolism in the electron transport chain are NADH (transfers electrons to molecular
oxygen) and FAD (electron acceptor). Our studies demonstrate that in P23H transgenic
retina there is a greater concentration of FAD and lower concentration of NADH
compared to normal SD retina indicative of the presence of oxidized mitochondria. In
the animals treated with 830nm light, there was a significant reversal in the FAD and
NADH signals reflected in the NADH RR and indicative of protection of normal
mitochondrial function and a reduction of oxidative stress.
Clinical Significance
The results of this study demonstrate retinoprotection mediated by NIR-PBM in a
well-established rodent model of RP. This protection was evident in structural, functional
and metabolic studies. Based on these findings, we suggest that NIR-PBM may represent
an innovative therapeutic approach for the treatment of retinal injury and the treatment of
retinal diseases, including AMD, glaucoma, diabetic retinopathy, and LHON where
mitochondrial dysfunction and oxidative stress play a central role in the pathology.
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CHAPTER 8
DISCUSSION AND CONCLUSIONS
Taken as a whole, the When taken together the studies presented in this thesis provides
novel insights into the putative mechanism for NIR PBM involving mitochondria which
leads to retinoprotective effects and emphasize the importance of harnessing the capacity
of damaged cells to self-repair for the treatment of inherited retinal degenerations like RP,
for which no current treatment strategies are available.
The current study was designed based on the growing body of evidence that exposure of
tissue to low energy photon irradiation in the far-red (FR) to near-infrared (NIR) range of
the spectrum (630-1000 nm) interacts with the mitochondrial enzyme cytochrome oxidase
inducing a cascade of signaling events that culminate in improved cell survival. FR/NIR
light has been shown to restore the function of damaged mitochondria, up-regulate the
production of cytoprotective factors and prevent apoptotic cell death in clinical and
experimental models of neurodegenerative diseases (Eells, Wong-Riley et al. 2004; WongRiley, Liang et al. 2005; Desmet, Paz et al. 2006; Fitzgerald, Bartlett et al. 2010).
The current studies have assessed the use of NIR PBM in non-dystrophic animal model.
These studies showed that PBM did not alter the functional and structural integrity of the
retina and support the safety of PBM which is essential to advance the therapy to clinical
use. In a non-dystrophic animal model there was no significant difference in structural
integrity and the functional response of the retina between active treatment group and the
sham control group. This result is of significant clinical importance and similar results are
reported in clinical trials in the treatment of radiation-induced mucositis and stroke
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(Lampl, Zivin et al. 2007) (Whelan, Connelly et al. 2002). Studies on the efficacy of NIR
PBM in non-dystrophic animal model support the hypothesis by our collaborators and
other investigators that preconditioning events may be triggered in healthy non challenged
retina at the cellular level by NIR PBM that leads to altered regulation of damaging genes
that respond differently in the presence of any cellular stress events. Lack of any apparent
effect was demonstrated in the sham control group after exposure to NIR photons in lightinduced retinal degeneration and methanol-induced retinal cytotoxicity models (Eells,
Henry et al. 2003) (Albarracin, Eells et al. 2011).
Mitochondria is shown to selectively absorb wavelengths 670 nm and 830 nm of the farred to near-infrared range of the electromagnetic spectrum (Greco, Guida et al. 1989).
Using action spectrum studies, Wong-Riley et al. demonstrated that 670-nm and 810-nm
photon irradiation rescued visual cortical neurons from cyanide-mediated cytotoxicity
(Wong-Riley, Liang et al. 2005). Karu et al. reported that the mitochondrial photoacceptor
molecule, cytochrome c oxidase has distinct absorption bands in the red (~665 nm) and in
the NIR (~810 nm) region of the electromagnetic spectrum (Karu, Pyatibrat et al. 2005).
The work presented has shown that the effect of 830nm PBM is more robust than 670 nm
PBM in preserving retinal function and structural integrity in P23H transgenic model of
RP. Recently Albarracin et al. demonstrated that 670nm PBM attenuated bright-light
induced retinal degeneration in albino rats (Albarracin, Eells et al. 2011). In our studies
using the P23H model of retinal degeneration we did not see protection with 670 nm PBM.
An important difference in the two studies is the dose of the light. In our study, rats were
treated for 90 sec at 60 mW/cm2 resulting in a dose of 5.4 J/cm2. In the Abarracin study,
rats were pre-treated for 180 sec at 60 mW/cm2 resulting in a dose of 10.8 J/cm2.
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Comparing the efficacy of 830nm photobiomodulation using three different treatment
paradigms- photobiomodulation during the critical period of photoreceptor degeneration
(p10-p25), photobiomodulation during the onset of the critical period of photoreceptor cell
death to young adulthood (p10-p 40) and photobiomodulation during the later stage (p20-p
40) to rescue remaining photoreceptors was essential to characterize the most effective
treatment window using 830 nm photons and with the current P23H transgenic model used
in this study we report that the effective time period to perform 830nm PBM to attenuate
disease progression is the ‘critical period’ of photoreceptor degeneration. Studies’
demonstrating the prolonged effect of brief photobiomodulation treatment implies
interaction of NIR photons at the cellular level induces a cascade of events leading to the
stimulation of gene expression, protein synthesis, and oxidative metabolism (Eells, Henry
et al. 2003). The functional rescue of photoreceptors in p10-p 40 paradigm demonstrates
the ability to use 830 nm photons from onset of the disease extending to adulthood. Future
experiments will be designed to validate the efficacy of extended treatment protocols.
Variability in the onset and presentation of clinical symptoms in RP with individuals
having same mutation is challenging. The structural and functional preservation of
photoreceptors in p20-p40 paradigm by 830nm photobiomodulation holds promise for the
use of NIR PBM during the later stages of degeneration process.
Oxidative stress associated with mitochondrial dysfunction play a key role in the
pathogenesis of RP and in other retinal degenerative disorders including glaucoma, age
related macular degeneration (AMD) and diabetic retinopathy (Kong, Tanito et al. 2007;
Kong, Van Bergen et al. 2009; Karunadharma, Nordgaard et al. 2010). To the best of our
knowledge, this thesis demonstrate the first attempts to provide a direct analysis of the
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cellular metabolic state within the mitochondrial compartment of the retina of P23H
transgenic rat model of RP by imaging endogenous fluorophores using novel optical
cryofluorescence imaging technique that has very high sensitivity and specificity (Chapter
5). NADH redox ratio, acts as a quantitative marker of the mitochondrial redox and
metabolic state of tissue ex vivo and in vivo (Ranji, Jaggard et al. 2006; Ranji, Kanemoto et
al. 2006; Sepehr, Staniszewski et al. 2012). Our findings showed that P23H transgene
caused a significant increase in the oxidized forms (NAD and FAD) of the coenzymes
NADH and FADH2 and NIR PBM by 830 nm reduced the NAD and FAD in the
degenerating retina significantly there by altering the NADH redox ratio. The redox
alterations observed in mitochondria results in the activation of intracellular signaling
cascades which culminate in improved mitochondrial function, increased synthesis of
cytoprotective factors and cell survival. We observed an increase in signal intensity in the
eye samples from the vitreous in both NADH and FAD channels that needs to be further
investigated and explained.
Use of NIR PBM may be a challenge in individuals having inherited or induced retinal
degeneration with anterior segment anomalies (e.g. primary defects in lens) of the eye
which will interfere with the delivery of photons to the retina and it should be addressed
while recruiting people in clinical trials.
The functional, structural and metabolic insights obtained from the current study provides
crucial information needed for clinical trials and FDA approval for the use of NIR-LED
devices in the treatment of retinal degenerative diseases. By harnessing the potential of
damaged cells to self-repair, photobiomodulation may provide an innovative and non-
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invasive therapeutic approach for the prevention and treatment of retinal degenerative
disease.
Future Directions
Although photobiomodulation by NIR photons is extensively used by researchers to
demonstrate preservation and stimulation of cellular events in various clinical and
experimental animal models the use of photobiomodulation is still controversial and
debated because of the incomplete knowledge of the mechanism of action and the
differences in the treatment parameters used by various investigators like range of
wavelength, dose, and the nature of light source- Laser vs. non-coherent light ; polarized
vs. unpolarized; pulsed vs. continuous wave (Posten, Wrone et al. 2005; Quirk and Whelan
2011; Wu, Xuan et al. 2012) (Chung, Dai et al. 2012). The altered kinetics of the
photoacceptor molecule (cytochrome c oxidase) after NIR photon interaction and the how
it alters the mitochondrial redox state that triggers secondary signaling cascades which
culminate in improved mitochondrial function remains a ‘‘black box’’ and future
experiments should emphasize to resolve the above issues.
This thesis validated the safety of using NIR photobiomodulation in non-dystrophic rats in
which animals are treated from p10-p25, which is the critical period of photoreceptor
development, however, it is crucial to demonstrate that photobiomodulation does not
adversely affect retinal function, metabolism and retinal architecture during prolonged
treatment paradigms. So far there are no reported adverse effects of PBM in experimental
and clinical studies (Whelan, Buchmann et al. 2003; Lampl, Zivin et al. 2007; Oron, Oron
et al. 2012). Recent studies from our collaborators in alpha-synuclein transgenic mice
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model of Parkinson’s disease showed no evidence of adverse effects in which animals
were treated daily with 670 nm PBM for more than a year (Quirk, Desmet et al. 2012).
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APPENDIX
Conference Proceedings
ARVO 2011
830 nm Photobiomodulation Attenuates Retinal Degeneration in a Rodent Model of
Retinitis Pigmentosa
S.Gopalakrishnan1, B.Abroe1, H.Schmitt1, A.Dubis2, P.Summerfelt2, J.Caroll2 and J.T.
Eells1. University of Wisconsin-Milwaukee, WI1, Medical College of Wisconsin,
Milwaukee, WI2
Purpose: Irradiation by light in the far-red to near-infrared (NIR) region of the spectrum
(photobiomodualtion, PBM) has been demonstrated to attenuate the severity of
neurodegenerative disease in experimental and clinical studies. The purpose of this study
was to test the hypothesis that a brief course of 830 nm PBM would protect against the
loss of retinal function and improve photoreceptor survival in a rodent model of retinitis
pigmentosa.
Methods: P23H-1 pups were treated once per day for 180 seconds with 830 nm light (25
mW/cm2; fluence 4 J/cm2) using a light-emitting diode array (Quantum Devices,
Barneveld WI) from postnatal day p10 to p25. Sham-treated rats were restrained for 180
seconds, but not exposed to NIR light. The status of the retina was determined at p30
by measuring indices of photoreceptor function by ERG (scotopic series from
100mcd.s/m2 to 25000mcd.s/m2) and retinal morphology by Spectral Domain Optical
Coherence

Tomography

(SD-OCT;

line

scans

centered

on

the

ONH,

1000x80x1samplings; Bioptigen, Inc). Following SD-OCT analysis, animals were
euthanized and the eyes harvested and prepared for histological and molecular analysis.
Results: 830 nm PBM protected against retinal degeneration in the P23H rat as assessed
by ERG and SD-OCT. In NIR treated animals the a-wave amplitude at 1000 mcd.s/m2
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was 117 ± 10 µV compared to 77 ± 7 µV in sham treated animals (p=0.007). The b-wave
amplitude in NIR treated rats was 643 ± 49 µV compared to 415 ± 27 µV in sham treated
animals (p=0.002). Total retinal thickness measured by SD-OCT linear scans was 179 ±
8 µm in NIR treated animals compared to 147± 8 µm for sham treated animals (p=0.04).
Conclusions: Studies from our laboratory have documented preservation of retinal
function and attenuation of photoreceptor loss by PBM in animal models of
mitochondrial injury and light-induced retinal degeneration. Results from this study
demonstrate the retinoprotective effects of 830nm PBM in a transgenic animal model of
retinitis pigmentosa and support the use of PBM as an innovative, non-invasive
therapeutic approach for the treatment of retinal degenerative disease.
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670 nm Photobiomodulation Attenuates Light-Induced Retinal Degeneration
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Purpose: Irradiation by light in the far-red to near-infrared (NIR) region of the spectrum
(photobiomodulation; PBM) has been demonstrated to attenuate the severity of
degenerative retinal diseases in experimental and clinical studies. The cytoprotective
actions of NIR-PBM have been attributed to improved mitochondrial energy production
and the up regulation of cytoprotective factors. The purpose of this study was to test the
hypothesis that a brief course of 670 nm photobiomodulation would protect against the
loss of retinal function, prevent mitochondrial dysfunction and attenuate photoreceptor
loss in the light damaged retina. Methods: The eyes of adult female Sprague Dawley rats
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(250 g) were treated with 670 nm light for 90 sec at 50 mW/cm2 (fluence = 4.5
joules/cm2 ) using a light emitting diode array (Quantum Devices, Inc). Rats were treated
once per day for 5 days prior to light damage [LD] (1500 lux for 24 h). Sham treated LD
rats were restrained for 90 sec, but not exposed to 670 nm PBM. At day 7 following LD,
retinal function was examined by ERG. At day 14, eyes were enucleated. One eye was
prepared for histological evaluation and the retina from the other eye was removed, snap
frozen and stored at -80 C for future analysis of mitochondrial function and antioxidant
concentrations. Results: 670 nm photobiomodulation protected against LD-induced loss
of rod and cone function. In sham-treated LD animals rod-mediated b-wave amplitude
was 320 ± 78 mV compared to 450 ± 65 mV in NIR-treated LD rats. The rod-mediated
b/a ratio was 14 ± 4 in sham-treated LD animals and 22 ± 6 in NIR-treated LD animals (p
< 0.05). The cone-mediated b-wave in LD rats was 103 ± 9 mV compared to 165 ± 25
mV (p < 0.05) in NIR-treated LD rats.Conclusions: Previous studies in our laboratory
have demonstrated neuroprotective and retinoprotective actions of 670 nm PBM light
treatment in vitro and in vivo. The present study extends these findings to include
protection against light-damage induced photoreceptor dysfunction. Given the reliance of
photoreceptors on mitochondrial oxidative metabolism and the evidence for LD-induced
mitochondrial injury, we speculate that the observed retinoprotective actions of NIR
PBM are due, in part, to the prevention of photoreceptor mitochondrial dysfunction and
the induction of mitochondrial repair in retinal light damage.
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